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Abstract:
Ribosome tagging has become a very useful in vivo approach for 
analyzing gene expression and mRNA translation in specific cell types 
that are difficult and time consuming to isolate by conventional methods. 
 The approach is based on selectively expressing an HA-tagged 
ribosomal protein in a target cell type and then using antibodies against 
HA to purify the polysomes and associated mRNAs from the target cell. 
 The original approach makes use of a mouse line (RiboTag) harboring a 
modified allele of Rpl22 (Rpl22-HA) that is induced by the action of Cre 
recombinase.  The Rpl22-HA gene can also be introduced into the animal 
by stereotaxic injections of an AAV-DIO-Rpl22-HA that is then activated 
in Cre-expressing cells.  Both methods for tagging ribosomes facilitate 
the immunoprecipitation of ribosome bound mRNAs and their analysis by 
qRT-PCR or RNA-Seq.  This protocol will discuss the technical procedures 
and describe important considerations relevant to the analysis of the 
data.
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Abstract:
Ribosome tagging has become a very useful in vivo approach for analyzing gene expression 
and mRNA translation in specific cell types that are difficult and time consuming to isolate by 
conventional methods.  The approach is based on selectively expressing an HA-tagged 
ribosomal protein in a target cell type and then using antibodies against HA to purify the 
polysomes and associated mRNAs from the target cell.  The original approach makes use of a 
mouse line (RiboTag) harboring a modified allele of Rpl22 (Rpl22-HA) that is induced by the 
action of Cre recombinase.  The Rpl22-HA gene can also be introduced into the animal by 
stereotaxic injections of an AAV-DIO-Rpl22-HA that is then activated in Cre-expressing cells.  
Both methods for tagging ribosomes facilitate the immunoprecipitation of ribosome bound 
mRNAs and their analysis by qRT-PCR or RNA-Seq.  This protocol will discuss the technical 
procedures and describe important considerations relevant to the analysis of the data.
[*Copy Editor – query authors for keywords]
Introduction:
The analysis of gene expression provides a description of a cell's potential functions and its 
response to extracellular signals.  However, when researchers attempt to analyze gene 
expression in vivo they are confronted with the problem that all tissues contain a diverse array 
of different cell types with unique functions.  Efforts to isolate a specific cell type for analysis 
based on sorting techniques can be successful but these additional manipulations are both time 
consuming and have been shown to alter transcription (Haimon et al., 2018).  The brain is a 
particularly challenging tissue in which to quantitate gene expression and translation. A typical 
mouse brain is made up of around 75 million neurons, 23 million glial cells, 7 million endothelial 
cells and several million other miscellaneous cell types (Williams, 2000).  Neurons are 
extremely diverse in terms of their expression of various neurotransmitters, neuropeptides, and 
receptors and typically these neurons are anatomically intermingled making them very difficult to 
separate for molecular analysis.  In situ analysis of mRNA expression has been very useful in 
identifying the overall anatomical distribution of neurons expressing specific genes and the Allen 
Brain Institute has assembled a comprehensive database for both the mouse and human brain 
which is very useful.  However, anatomical localization cannot define specific neuronal cell 
types.  Characterization of the mRNA expression phenotype of specific neurons has progressed 
with the development of ribosome-tagging approaches, cell sorting based on promoter specific 
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expression of fluorescent marker proteins, and single-cell RNA-Seq.  Each approach has 
advantages and disadvantages. In this protocol we describe a ribosome-tagging approach 
(RiboTag) which our lab developed (Sanz et al., 2009) and discuss the application of this 
approach to the analysis of polyribosome associated mRNA transcripts in specific populations of 
neurons.  The RiboTag approach takes advantage of the hundreds of specific promoter-driven 
Cre recombinase transgenics currently available (Jackson Laboratories has more than 480 
lines) and others are being added at a rapid pace. 
There are two basic approaches involving the use of RiboTag as diagrammed in Figure 1 and 
each has advantages and disadvantages.  In the first approach we use a RiboTag mouse line in 
which the 60S ribosomal gene, Rpl22, was modified so that in the presence of Cre recombinase 
the last exon of Rpl22 will be replaced with an HA-tagged exon effectively labeling the cell's 
polyribosomes so that they can be isolated by immunoprecipitation.  These RiboTag mice are 
crossed to a Cre recombinase driver mouse line and the double heterozygotes are used for 
analysis.  Immunoprecipitation of polyribosomes from neuronal tissue purifies only the 
polysomes that are tagged in the Cre-expressing cells.  The mRNA from these polysomes is 
isolated and the transcripts analyzed by qRT-PCR or RNA-Seq. The second approach utilizes a 
Rpl22-HA construct in a flex or DIO virus (AAV) flanked by two different sets of loxP sites (Sanz 
et al., 2015).  When the AAV-DIO-RiboTag is injected into a specific anatomical region of the 
brain of an adult mouse the Rpl22-HA is only expressed in the neurons that are actively 
expressing Cre recombinase and also infected by the AAV.  After waiting several weeks for the 
Rpl22-HA to be expressed and incorporated into polyribosomes, tissue samples are isolated 
and used to immunoprecipitate HA-tagged polyribosomes followed by qRT-PCR or RNA-Seq.  
The viral approach requires accurate stereotaxic injections of virus and is more labor intensive 
but has the advantage that only adult neurons that still express the Cre transgenic will be 
targeted.  The direct cross of RiboTag mice with Cre driver mice is easier to do but has the 
potential disadvantage that the Rpl22-HA could continue to be expressed in neurons that have 
differentiated from a progenitor population that expressed Cre recombinase at an earlier stage 
during development.  One can take advantage of this difference by comparing results from the 
same brain region using the RiboTag mouse and the RiboTag virus using the same Cre driver 
transgenic.  We have used this approach to demonstrate that embryonic Pomc-expressing 
progenitor neurons differentiate into both Agrp and Kiss1 expressing neurons in the adult 
arcuate nucleus of the hypothalamus (Sanz et al., 2015).  
[*Copy Editor – place Figure 1 here]
Basic Protocol 1 outlined below describes our methods in detail using the RiboTag mouse 
crossed with a specific Cre-recombinase expressing transgenic mouse to isolate polyribosomes 
by immunoprecipitation from brain homogenates and then further isolate RNA from both the 
input (original homogenate) and the immunoprecipitated (IP) polysomes.  Alternative Protocol 
1 describes the viral approach using stereotaxic injection of AAV-DIO-RiboTag into adult Cre-
recombinase expressing mouse brain to avoid developmental activation of RiboTag expression.  
In Support Protocol 1 we describe the breeding and genotyping of RiboTag mice and in 
Support Protocol 2 we describe the analysis of captured RNA using qRT-PCR.  Basic 
Protocol 2 discusses the use of RiboTag mice crossed with a specific Cre transgenic line to 
identify the anatomical localization of RiboTag expression by immunohistochemistry.  In Basic 
Protocol 3 we describe the current approach our lab is using to produce DNA libraries for RNA-
Seq. Basic Protocol 4 describes the bioinformatic tools that we are using to analyze the RNA-
Seq data.  In the Commentary we will provide a discussion of these methods and identify some 
of the most critical parameters and potential trouble spots.
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BASIC PROTOCOL 1
The RiboTag Assay
This approach has been described and updated in several publications from our laboratory 
(Quintana et al., 2012; Sanz et al., 2013; Sanz et al., 2015; Sanz et al., 2009) and is shown 
schematically in Figure 1. We have now introduced modifications that improve the efficiency of 
the immunocapture and therefore increase the RNA yields obtained in the immunoprecipitates. 
These modifications include using an indirect method for the immunocapture of HA-tagged 
polysomes (instead of the direct immunoprecipitation procedure described in the original 
publication) and using Protein A/G beads with a higher binding capacity for IgGs.
Materials:
Mice:
RiboTag mouse line (JAX stock No. 011029)
Cre-driver mouse line of choice
Equipment:
Large sharp surgical scissors (FST cat No. 14001-14)
Small extra fine scissors (FST cat No. 14084-08)
Spatula (FST cat No. 10091-12) 
Harris Uni-Core (Electron Microscopy Sciences cat No. 69036)
Razor blades (Electron Microscopy Sciences cat No. 71960) 
Mouse brain matrix (Electron Microscopy Sciences cat No. 69022)
Glass Dounce homogenizers (2ml or 7ml) (Sigma cat. No. 8938 or 9063)
Refrigerated centrifuge (Eppendorf; cat. No. 5417R) with rotor for 1.5 ml microcentrifuge tubes.
Microcentrifuge tubes (Axygen; MCT-175-C)
10 ul ART Barrier pipette tips (Thermo Fisher Sci.; cat. No. 2140-HR)
20 ul ART Barrier pipette tips (Thermo Fisher Sci.; cat. No. 2149-HR)
200 ul ART Barrier pipette tips (Thermo Fisher Sci.; cat. No. 2069-HR)
1000 ul ART Barrier pipette tips (Thermo Fisher Sci.; cat. No. 2179-HR)
Microtube magnetic stand (Thermo Fisher Sci.; cat. No. 12320D)
Microtube rotator (Thermo Fisher Sci.; cat No. 88881002)
Nanodop One (Thermo Fisher Sci.; cat. No. 13-400-518)
Fluorescence microplate reader (for Quant-iT Ribogreen RNA assays)
2100 Bioanalyzer Instrument (Agilent; cat. No. G2939BA)
Materials:
Sterile water for irrigation (Baxter, cat. No. 2F7114)
1M DTT, 10X 0.5ml ampules (Sigma; cat. No. 646563-10X 0.5ml). Aliquot open ampules and 
store at -80ºC
Protease inhibitor cocktail (Sigma, cat. No. P8340-5ml). Aliquot and store at -20C
RNAsin (40U/ul) (Promega, cat. No. N2115)
b-mercaptoethanol (Bio-Rad; cat. No.1610710
Pierce protein A/G magnetic beads (Thermo Fisher Sci.; cat. No. 88803)
Covance Anti-HA.11 Epitope Tag Antibody (BioLegend; cat. No. MMS-101R). Aliquot and store 
at -20ºC
RNeasy Mini Kit (Qiagen; cat. No. 74104) or RNeasy Micro kit (Qiagen; cat. No. 74004)
Quant-iT RiboGreen RNA Assay kit (Thermo Fisher Sci.; cat. No. R11490)
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RNA 6000 Nano kit or RNA 6000 Pico kit (Agilent; cat. No. G2939BA, 5067-1511 or 5067-1513)
Ethanol (200 proof)
Protocol steps:
Harvest tissue
1. Euthanize mice using IACUC approved procedures such as carbon dioxide inhalation
2. Decapitate mice using large sharp surgical scissors 
3. Make a midline incision in the skin and expose the skull
4. Using small scissors and a spatula remove the skull
5. Lift the brain out of the skull and use a spatula to section the optic and other cranial 
nerves
6. Place the brain in a cold block or brain matrix for further dissection. Sampling tools such 
as Harris Uni-cores can be used to punch the area of interest.
Lysate preparation
7. Clean Dounce tissue grinder and dissection tools and rinse thoroughly with RNase-free 
water (sterile water for irrigation can be used at this step). Air dry and place Dounce 
homogenizer on ice.
8. Prepare the homogenization buffer as described in the Reagents and Solutions section 
and keep on ice.
9. Dissect the tissue containing the cell type of interest. Specific areas or whole tissue can 
be used in this approach. 
A brain matrix and sampling tools such as brain punches or Harris Uni-Cores can be 
used to precisely dissect the area of interest. Dissected tissue or punches of the area 
of interest can either be flash-frozen in liquid nitrogen right after dissection and 
stored at -80ºC for months or processed fresh.  
10. Place the tissue in the ice-cold Dounce homogenizer vessel containing a defined volume 
of pre-chilled homogenization buffer and homogenize using 40 strokes of the loose-
fitting pestle (type A pestle), followed by 40 more strokes with the tight-fitting pestle (type  
B pestle). 
We typically use a 2-5% w/v ratio (for areas with a limited number of cells from the 
cell type of interest a pool of punches of the same area from different animals can be 
used to increase RNA yields). For small amounts of tissue (10-50mg tissue) we use 
the 2 ml Dounce and for 50-300mg we use the 7 ml Dounce.
11. After homogenization, transfer lysate to a microtube on ice.
12. Clear the lysate at 10,000 x g for 10 min at 4ºC using a refrigerated centrifuge.
13. Transfer the post-mitochondrial supernatant to a pre-chilled microcentrifuge tube on ice. 
Discard resulting pellet. 
14. Take a small aliquot of the cleared lysate (40-80 ul) and store it at -80ºC for subsequent 
Input analysis.
Immunoprecipitation
15. Add 4 ul of the anti-Hemagglutinin (HA) antibody (Covance Anti-HA.11 Epitope Tag 
Antibody) to 800 ul of the remaining cleared lysate and incubate for 4 hours at 4ºC in a 
microtube rotator with gentle mixing (end-over-end).
16. Prepare the magnetic protein A/G beads: 
 Thoroughly resuspend the beads by repeated inversion or gentle vortexing.
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  Place a microtube magnetic stand on ice and transfer 200 ul of the resuspended 
beads to a clean microcentrifuge tube. 
 Place the tube into the magnetic stand on ice to collect the beads and remove 
and discard the storage buffer. 
 Add 400 ul of homogenization buffer and rotate end-over-end for 5 min to wash 
the beads. 
 Collect the beads with the magnetic stand, discard buffer.
17. Add the cleared lysate with the antibody to the beads. Incubate samples overnight at 
4ºC in a tube rotator with gentle end-over-end mixing. 
18. Next day, prepare the high salt buffer as described in the Reagents and Solutions 
section. Keep on ice.
a. Place samples into the magnetic stand on ice and remove supernatant 
(supernatant from the immunoprecipitation can be discarded or saved at -80ºC 
for subsequent analysis). 
Leave tubes in the magnet for at least one minute to collect all the beads 
against the side of the tube. 
19. With the tubes on the stand, add 800 ul of high salt buffer (Reagents and Solutions) to 
remove non-specific binding from the immunoprecipitate (IP). Transfer tubes to the 
rotator and wash the IP with gentle end-over-end mixing for 5 min at 4ºC. 
20. Place samples into the magnetic stand on ice and remove supernatant
21. Repeat high salt washes two more times with the same volume of high salt buffer for 5 
min each, for a total of three washes.
22. Resuspend beads in 800 ul of high salt buffer, mix on rotator for 5 min and transfer 
beads and buffer to a clean tube.
This step helps remove any RNA or polyribosomes that might be sticking to the 
original tube.
23. Place tubes on the magnetic stand for at least 1 min, carefully remove all high salt buffer 
24. Add 350 ul of RLT buffer from the Qiagen’s RNeasy extraction kit (mini or micro) 
supplemented with -mercaptoethanol (provided with the kit). 
25. Remove tubes from stand and vortex samples for 30 seconds at RT. 
At this step samples can be stored at -80ºC for subsequent RNA extraction or 
processed through the RNA extraction procedure.
RNA extraction 
26. Place tubes containing IPs in RLT buffer (from Qiagen kit) into the magnetic stand for 1 
min at RT to allow beads to be collected against the side of the tube 
27. Transfer the clear RLT buffer containing RNA to a new microcentrifuge tube. 
28. Proceed with RNA isolation with DNAse digestion following Qiagen's RNeasy extraction 
kit directions. 
29. To extract RNA from the Inputs (Step 6), bring input sample to 350 ul with RLT buffer 
supplemented with -mercaptoethanol, vortex extensively and proceed to RNA 
extraction as described for IPs. 
RNA extraction using column-based kits should be performed at RT. However, 
eluted RNA should be kept on ice at all times. For long term storage, RNA is 
safely kept at -80ºC for years. Whenever working with isolated RNA, always wear 
gloves to minimize RNase contamination, decontaminate working surfaces and 
use clean nuclease-free tubes and barrier pipette tips.
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30. Quantitate RNA using Quant-iT RiboGreen RNA Reagent (Thermo Fisher) or a 
Nanodrop-One (Thermo Fischer Sci) following the manufacturer's protocols.
If very low levels of RNA are expected (less than 2 ng/ul) the samples can be 
accurately quantitated by doing qRT-PCR using a house keeping gene such as 
Actb and comparing the results to known standard RNA solutions prepared with 
input RNA from the same tissue as detailed in Support Protocol 2.
31. Analyze RNA integrity on an Agilent 2100 Bioanalyzer system with the associated RNA 
6000 nano and pico kits (chose nano chips for samples 5-500 ng/ul, for samples with 
RNA concentrations < 5 ng/ul (down to 50 pg/ul) the pico chips should be used). Follow 
manufacturer’s directions.
Since most of the RNA isolated in Inputs and IPs is rRNA, the quality of mRNA is 
indirectly estimated by assessing the integrity of rRNA. A measure of RNA 
quality, the RNA integrity number (RIN), is also calculated by the software using 
an algorithm that assesses the electrophoretic traces of each sample. A RIN 
value of 7-10 indicates high quality RNA but RNA-Seq libraries can still be made 
and successfully analyzed starting with partially degraded RNA.
ALTERNATE PROTOCOL 1
Messenger RNA profiling using the RiboTag viral vector
To overcome the limitations associated with developmental activation of Cre 
recombinase transgenes and allow cell type-specific mRNA profiling of adult cells using 
Cre-Driver lines, we have developed a Cre-dependent RiboTag viral vector based on 
AAV1 (AAV1-DIO-RiboTag) (Sanz et al., 2015), where RiboTag expression is dependent 
on the activity of the promoter driving Cre recombinase expression in adult mice. This 
viral vector was created by inserting the cDNA of the mouse ribosomal protein Rpl22 
gene fused to three hemagglutinin (HA) sequences (Rpl22 · 3HA), into a double-floxed 
inverse open reading frame (DIO) AAV construct. For easy visualization of transduced 
cells, this construct also contains an IRES sequence (IRES2) followed by the YFP 
coding sequence as shown in Figure 1.
Materials:
Mice:
Cre-driver mouse line of choice.
Reagents:
RiboTag viral vector (AAV1-DIO-RPL22HA-IRES-YFP). Available upon request from authors
Equipment:
Stereotaxic apparatus with microsyringe pump (e.g. from World Precision Instruments)
Injection syringe (e.g. 5 ul Hamilton syringe)
Surgical tools 
Protocol steps:
1. Define stereotaxic coordinates by locating the injection target in a mouse brain atlas 
such as the Paxinos and Franklin’s “the Mouse Brain in Stereotaxic Coordinates” 
Page 6 of 56
John Wiley & Sons
Current Protocols
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
(Paxinos & Franklin, 2013) or the Allen institute for Brain Science’s “Adult Mouse Brain 
Reference Atlas” (Dong)
2. Inject 0.2 to 0.5 ul of a RiboTag viral vector preparation (7 x 1011 viral genomes/ml) at 
the target site using the defined coordinates. 
Follow a stereotaxic injection protocol such as (Gore, Soden, & Zweifel, 2013). 
When targeting bilateral structures, inject each side. Injection volumes can be 
adjusted to the targeted area, or multiple injections performed to cover larger 
areas. Injecting different mice using the same coordinates and pooling the 
targeted areas after dissection helps correct for variability resulting from 
stereotaxic viral vector injections.
3. Allow at least 2 weeks for the viral vector to express Rpl22-HA. For RiboTag assays, 
good results are obtained when sacrificing animals at least 3 weeks after injections to 
allow for robust incorporation of Rpl22-HA into polyribosomes. 
4. Perform RiboTag immunoprecipitations as described in Basic Protocol 1
All surgical procedures should be performed in accordance with protocols approved by your 
Institutional Animal Care Use Committee (IACUC).
SUPPORT PROTOCOL 1   Breeding and Genotyping of RiboTag Mice
Breeding of RiboTag Mice:  
We maintain a live colony of RiboTag Breeders on a C57BL/6J background by mating 
homozygotes since they have no adverse phenotypes. Experimental mice for RiboTag 
assays are usually obtained by breeding male Cre recombinase-expressing mice to 
female homozygous RiboTag mice (Rpl22HA/HA), Therefore, experimental mice are 
always heterozygous for the RiboTag allele (Rpl22HA/+). 
PCR Genotyping:  
To genotype the RiboTag mice, a PCR was developed that includes the loxP site 5’ to 
the wild-type exon 4 of Rpl22; the wild-type PCR product is 242 bp, while the mutant 
product is about 290 bp. This PCR also distinguishes homozygous RiboTag mice, as the 
5’ oligo corresponding to the intron between exons 3 and 4 of Rpl22 is not present in the 
repeated segment of intron preceding the C-terminal Rpl22HA exon 4. Resulting 
offspring from RiboTag mice bred to Cre recombinase-expressing mouse lines 
(experimental mice) are genotyped for the presence of the Cre recombinase gene and 
the RiboTag allele using the PCR oligonucleotides and reaction conditions described 
below
Materials:
NucleoSpin Tissue DNA extraction kit (Macherey-Nagel cat No. 740952)
DreamTaq DNA polymerase (Thermo Fisher Sci. cat No. EP0702 and B71)
dNTPs 10 mM each (Thermo Fisher Sci. cat No. R0192)
 (dilute to 2.5 mM for each dNTP) 
Alternative:
Phire Tissue Direct PCR Master Mix kit (Thermo Fisher Sci. cat No. F170
Oligonucleotides for RiboTag genotyping:
RiboTag loxP For: 5’-GGGAGGCTTGCTGGATATG-3’ 
RiboTag loxP Rev: 5’-TTTCCAGACACAGGCTAAGTACAC-3’
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Oligonucleotides For Cre recombinase genotyping:
Cre cDNA For: 5’-GCATTACCGGTCGATGCAACGAGTG-3’ 
Cre cDNA Rev: 5’-GAACGCTAGAGCCTGTTTTGCACGTTC-3’
Acrylamide-bis solution 40% (37.5:1) (Merck cat No. 1.00638.1000)
Tris-Borate-EDTA (TBE) 10x (Fisher Scientific cat No. BP1333)
Ammonium Persulfate (APS; Sigma cat No. A3678).
(Prepare a 10% solution. Store at 20ºC.)
TEMED (Merck cat No. 1.10732.0100)
SYBR Safe DNA gel stain (Thermo Fisher Sci. S33102)
100 bp DNA ladder (Thermo Fisher Sci. cat No. SM0241)
Equipment:
Thermal cycler (Thermo Fisher Sci. cat No. A24811)
Mini protean vertical gel electrophoresis system (Bio-Rad cat No. 1658003)
Power supply (Bio-Rad cat No. 1645050)
UV Gel imaging system 
Strip tubes and caps for PCR
Protocol steps:
1. Extract DNA from mouse tail snips (2-5 mm) using a silica membrane column-based 
kit such as the NucleoSpin Tissue following manufacturer’s directions. 
We have also successfully used direct PCR kits that do not require prior DNA 
extraction such as the Phire Tissue Direct PCR Master Mix kit for RiboTag and 
Cre recombinase genotyping. DNA can also be extracted from tail samples by 
conventional methods using SDS/Protease K digestion, phenol/chloroform 
extraction, and ethanol precipitation.
2. Prepare the DreamTaq PCR Master mix as follows: (per reaction) 13 µl of water, 2 µl 
of 10x DreamTaq green buffer, 2 µl of 10mM dNTPs, 1 µl of the forward oligo 
(10uM), 1 µl of the reverse oligo (10uM), 0.1 µl of DreamTaq polymerase. Mix gently 
and briefly centrifuge.
3. Add 19 µl of the master mix to each well.
4. Add 1 µl of tail DNA (~2 ng) to each reaction. 
5. Mix and briefly centrifuge.
6. Place strips in the thermal cycler and run the appropriate program for each reaction. 
Thermal profile for RiboTag reactions is: 95°C for 2 min followed by 30 cycles of 
95°C for 20 s, 57°C for 20 s, and 72°C for 30 s, with a final extension at 72°C for 5 
min. Thermal profile for Cre reactions is 95°C for 2 min followed by 30 cycles of 95°C 
for 10 s, 63°C for 10 s, and 72°C for 40 s, with a final extension at 72°C for 5 min.
7. Prepare a 10% acrylamide gel by mixing (for two gels) 14 ml of water, 5 ml of 40% 
acrylamide-bis, 1ml of TBE 10x, 30 µl of TEMED and 150 µl of 10% APS. Allow gels 
to polymerize for 10-15 min.
8. Place gels into a vertical gel electrophoresis system, add buffer (0.5X TBE), and load 
DNA ladder and PCR reactions. 
9. Run the electrophoresis at 175v (constant voltage) for 45 min. 
10. Stain gels with SYBR safe and analyze PCR products under UV light. 
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Detecting “Ectopic” Cre Recombination in tail DNA
Mouse lines driving Cre recombinase expression under cell type specific promoters 
should typically restrict RiboTag activation to the cell type of interest. However, transient 
expression of Cre recombinase during development is often observed in different Cre 
driver lines and can lead to recombination of the RiboTag allele in unexpected cell types. 
If this “ectopic” expression takes place in the fertilized egg or during early development, 
it will be detected during the RiboTag genotyping PCR and a “recombination” band will 
show up at ~350 bp. If recombination occurs in the fertilized egg the loxP band will be 
replaced by the “recombination” band. If Cre recombinase is expressed during early 
development, recombination of the RiboTag allele will only take place in a portion of the 
cells and both the loxP and the recombination band will show up during PCR analysis. If 
genotyping heterozygous animals (Rpl22HA/+), the wild-type band will always be present 
in the PCR assay independently of the potential recombination events that may take 
place on the floxed allele. 
SUPPORT PROTOCOL 2  qRT-PCR analysis
The success of the RiboTag procedure can be assessed by using qRT-PCR to evaluate 
whether specific mRNAs have been enriched during the isolation.  Transcripts from the gene 
that is driving the Cre-recombinase in the specific cell types should be enriched in the IP RNA 
sample compared to the input RNA.  We also recommend monitoring mRNAs that are not 
expected to be expressed in the targeted cells to verify that they are de-enriched in the IP.  
Quantitative RT-PCR may substitute for a more expensive and time-consuming analysis by 
RNA-Seq when only a small subset of transcripts need to be assessed.
Materials:
Equipment:
Real-Time PCR machine
Reagents:
We use the one step Brilliant II or III SYBR green kits from Agilent or RNA-Ct one step 
kits from Thermo Fisher Sci.
1. To confirm the specific isolation of transcripts from the cell type of study, we analyze 
RNA extracted from Inputs and IPs by single-step qRT-PCR.  The enriched presence of 
known cell type-specific transcripts in the IPs compared to inputs indicates that the 
RiboTag isolation was successful.
2. Test samples for expression of transcripts specific to cell types in the dissected area 
other than the one of interest such as a glial marker when using a neuron-specific Cre 
transgenic. These are expected to appear depleted in the IPs when compared to inputs. 
3. Perform qRT-PCR analysis for a housekeeping gene such as Actb. Normalizing all data 
to that standard can help correct for errors in RNA quantitation or differences in RNA 
quality. Adding equal amounts of RNA to the qRT-PCR reaction for all samples results in 
little variation in the CTs obtained for the housekeeping gene (less than 1 CT of 
difference is expected among all samples), which confirms RNA integrity in all samples 
and suitability of the housekeeping gene for data normalization.
Page 9 of 56
John Wiley & Sons
Current Protocols
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 BASIC PROTOCOL 2:  RiboTag mice as a reporter mouse line for direct visualization of 
Cre recombination
Materials:
Mice:
RiboTag mouse line (JAX stock No. 011029)
Cre-driver mouse line of choice 
Reagents:
Normal Donkey Serum (Jackson ImmunoResearch cat. No. 017-000-121)
Zymed’s rabbit anti-HA antibody (Thermo Fisher Sci., cat. No. 71-5500
Covance’s Alexa Fluor 488-conjugated mouse anti-HA antibody (BioLegend,cat. No. A488-
101L)
Alexa Fluor 488 donkey anti-rabbit antibody (Thermo Fisher Sci., cat. No. A21206)
SuperFrost plus slides (Thermo Fisher Sci. cat No. J1800AMNT)
Coverslips 24 x 60 mm #1 (Menzel-Glaser, available through VWR cat No. 631-1339)
Fluoromount G with DAPI (Electron Microscopy Sciences, cat. No. 17984-24)
Equipment:
Netwells (Corning CLS3477)
Nutator mixer (e.g. Boekel or Clay Adams)
Paint brush
Protocol steps:
Tissue preparation
1. Transcardially perfuse mice with ice-cold phosphate-buffered saline (PBS) pH 7.4 
containing 4% paraformaldehyde (PFA). 
Perfusion with fixative solution reduces background resulting from endogenous 
mouse IgG detection when using anti-mouse secondary antibodies. If no primary 
antibodies raised in mouse are used for staining, brains can by directly fixed after 
removal by immersion in fixative for 12-24 h. 
2. Remove brains and postfix overnight at 4ºC in PBS pH 7.4 containing 4% PFA. 
3. Wash brains twice in ice-cold PBS pH 7.4
4. Immerse brains in an ice-cold solution of 30% sucrose in PBS pH 7.4. Specimens will 
float. Keep at 4ºC until they sink (about 24 h)
5. Remove brains from the cryoprotective solution and pat dry to remove excess solution
6. Freeze in powdered dry ice for 5 min and store at -80 ºC until sectioning.
7. Cryo-section brains in 30 um-slices using a freezing microtome. Collect sections from 
the area of interest for free-floating staining in PBS pH 7.4 with 0.02% sodium azide as 
preservative. Store sections at 4º.
Imunofluorescence
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8. Use a paint brush to transfer sections to wells containing Netwells inserts filled with PBS 
pH 7.4. Rinse sections once with PBS to remove preservative.
9. Block sections in PBS with 0.2% Triton X-100 and 10% normal donkey serum (NDS) for 
1 h at room temperature with agitation.
10. Incubate overnight at 4ºC with a primary antibody solution containing an anti-HA 
antibody such as the Zymed’s rabbit anti-HA (#71-5500 Thermo Fisher Sci; use at 
1:1000), or with a fluorophore-conjugated anti-HA antibody such as the Covance’s Alexa 
Fluor 488-conjugated mouse anti-HA antibody (# A488-101L BioLegend, use at 1:500), 
in PBS pH 7.4 with 1% NDS and 0.2% Triton X-100. 
Fluorophore-conjugated antibodies allow for a direct visualization of the signal 
without secondary antibody detection. Using fluorophore-conjugated secondary 
antibodies will however provide an amplified signal.
11. Wash sections three times for 5 minutes in PBS pH 7.4 with 0.2% Triton X-100. If a 
fluorophore-conjugated anti-HA antibody is used proceed to step 13. 
12. Incubate with secondary antibody solution containing an anti-rabbit antibody conjugated 
to the fluorophore of choice (e.g., Alexa Fluor 488; Invitrogen; 1:500 in PBS pH 7.4 with 
1% NDS and 0.2% Triton X-100) for 1 h at room temperature.
13. Wash sections three times for 5 minutes in PBS pH 7.4 with 0.2% Triton X-100
14. Mount stained sections onto slides for imaging using Fluoromount G with DAPI.
15. Seal the edge with nail polish and allow slides to dry for 1-2 hours before visualizing. 
Protect from light.
16. Slides can be stored at 4ºC protected from light. For best results, slides should be 
analyzed within 1-2 weeks using the microscope of choice. Staining using anti-HA 
antibodies in Cre-positive RiboTag mice results in a strong perinuclear signal in the cell 
type of interest. 
17. Image slides on a fluorescent microscope (standard or confocal) to visualize the Alexa 
Fluor 488 and DAPI.
DAPI will bind DNA and light up the nuclei in all cells and Alexa fluorescence will 
only be present in the cells that are expressing RiboTag.  Expect to see most of 
the RiboTag labeling in the cytoplasm where polyribosomes are abundant and in 
the nucleolar structures in the nucleus where ribosomes are being assembled.
BASIC PROTOCOL 3: RNA-Seq Library Preparation
There are many library preparation kits on the market but Trio RNASeq (NuGEN) has worked 
well in our hands. A detailed protocol is available on NuGEN’s website (NuGEN). Briefly, 500 pg 
– 50 ng of total RNA in a volume of 10 ul is used as starting material for samples. We 
recommend using similar quantities of RNA for all samples that are going to be compared with 
each by RNA-Seq.  We have good results starting with ~2 ng of total RNA.
Materials
Trio RNA-Seq, mouse rRNA, part number 0507-X; (X = 8, 32, or 96), (NuGEN)
AMPure XP, reference number A63880, (Beckman Coulter)
NEBNext Library Quant Kit for Illumina, catalog number E7630X (X = S, or L), (NEB)
NextSeq 500/550 High Output Kit v2.5 (75 Cycles), catalog number 20024906, (Illumina)
200 mM NaOH
200 mM Tris, pH 7.0
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0.2 mL PCR tubes (flat top optically clear)
1.5 mL microtubes 
0.2 mL tube magnetic rack 
Equipment:
Thermal cycler (PCR machine)
Quantitative thermal cycler
NextSeq Sequencer (Illumina)
Convert isolated RNA from RiboTag into cDNA libraries
1. Perform DNase treatment using the Trio RNASeq kit.  
Although DNA digestion is performed on the RNA purification column, the first 
step of the Trio RNASeq kit is to perform DNase treatment. It is extremely 
important to eliminate any residual DNA and the second DNase treatment does 
not result in any loss of sample. 
2. Synthesize cDNA from the total RNA using reverse transcriptase primed with both oligo 
dT and random hexamers and then use DNA polymerase to produce a double stranded 
cDNA molecule
These primers include an RNA sequence at the 5’ end that is not complementary 
and does not hybridize to the sample RNA. Then a second strand is made with a 
DNA polymerase (Dafforn et al., 2004; Kurn et al., 2005).  
3. Purify double stranded cDNA using silicon coated magnetic beads (AMPure XP, 
Beckman Coulter). 
These beads are used several times throughout the protocol adding various 
amounts of a salt containing bead binding solution. By varying the salt 
concentration in the reaction, one is selecting for different fragment sizes, with 
more salt attracting almost all fragment sizes and less preferentially selecting for 
larger fragments (Boom et al., 1990; Melzak, Sherwood, Turner, & Haynes, 
1996).
4. Amplify the double-stranded cDNA using single primer isothermal amplification (SPIA). 
RNase H is used to digest the RNA portion of the RNA / DNA heteroduplex at 
one end of the double stranded cDNA. A 5’ RNA 3’ DNA primer and a strong 
strand displacing DNA polymerase are used to make a single stranded cDNA 
that is the compliment to the original RNA. The process is continually repeated all 
at one temperature making many such copies (Dafforn et al., 2004; Kurn et al., 
2005). 
5. Fragment and repair ends of the cDNA
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The kit accomplishes this using an enzymatic process. After fragmentation 
adapters are ligated to either side of the cDNA with the 3’ side receiving a unique 
nucleotide barcode that will be used to identify samples after sequencing. 
6. PCR Amplification of cDNA products.  
The kit uses two PCR amplifications with a targeted step in between designed to 
deplete any cDNAs that would have been made from ribosomal RNA. Oligo 
probes are designed to bind to rRNA derived cDNA, extend that product, then 
restriction enzymes target these cleaving the adaptors off these products 
essentially eliminating them from the library. 
  
Quantify cDNA libraries
Even starting at the low end of the kit’s range 500 pg of total RNA, one ends up with 
micrograms of cDNA. This needs to be greatly diluted before sequencing. To get the 
best results from the sequencer the cDNA libraries must be loaded on at a precise 
quantity. As well, each sample that will be multiplexed together should be loaded in 
equal quantities. The most accurate way to quantify the cDNA libraries is using qPCR 
against the adaptors on the cDNA fragments. Again, there are many kits on the market 
that can accomplish this but NEBNext has worked well in our hands.
Four standard samples come with the kit ranging from 0.01 pM to 10 pM. In order to fall 
within these one needs to make serial dilutions of the libraries and use a range of those 
samples to quantify. In our hands 1:100,000 and 1:1,000,000 are the two dilutions that 
will fall between the given standards. Our libraries are most often between 0.1 and 1 µM. 
A detailed user manual is available on NEB’s website (NEB, 2017).
Denature and dilute libraries
The day of the sequencing run, libraries need to be denatured and diluted. A detailed 
protocol is available on Illumina’s website (Illumina, 2018a). 
1. Make a 1 nM dilution of each sample to be multiplexed together using a portion of the 
libraries made earlier. Add an equal amount of each 1 nM sample to a master sample.
2. Add 20 uL of the master sample to 20 uL of 0.2 M NaOH. Mix by pipetting half of the 
volume 10 to 20 times. Incubate for 5 minutes. 
3. Add 20 uL 0.2 M Tris pH 7 to neutralize the NaOH. Mix well by pipetting. 
4. Add 940 uL of prechilled HT buffer provided with the NextSeq reagents to make a 20 pM 
dilution. Vortex briefly then spin the contents down. Keep the 20 pM sample on ice until 
you are ready to make the final dilution.
5. Add 117 uL of the 20 pM sample to 1183 uL of prechilled HT buffer for a final dilution of 
1.8 pM in 1.3 mL. Vortex briefly then spin the contents down. Keep this on ice until you 
are ready to load this on the sequencer. 
Sequencing
1. Thaw reagents cartridge at 4 degrees overnight. Take the reagents cartridge and flow 
cell out of the refrigerator 30 minutes to an hour before your sequencing run. Ensure all 
reagent have thawed before proceeding.
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2. From the NextSeq500’s software interface select Sequence.
3. Following the instructions on screen, load the flow cell.
4. Empty the spent reagents container into the appropriate waste container, then reload. 
Load buffer cartridge. 
5. Pierce the foil covering reservoir 10 on the reagent cartridge with a pipette tip. Then load 
the full volume of the 1.8 pM sample into reservoir 10. Load the reagent cartridge onto 
the NextSeq500. 
6. Specify the run parameters on the setup screen. Assign a name to Run Name, enter 75 
into Read 1 and 8 into Index 1. 
Single end reads may be sufficient for gene expression quantification and 
differential gene expression analysis. Running paired end reads will increase 
alignment confidence for specific isoforms and for novel transcript discovery. In 
this case you would enter 75 into “Read 2”. NextSeq high output cartridges are 
rated for 400 million single end or 200 million paired end reads. 
7. Select Next, the system will run through a number of checks. Once it has finished with 
these select Start. 
A detailed user guide including  instructions for loading reagents and sample 
onto the NextSeq sequencer is available on Illumina’s website (Illumina, 2018b). 
Once reagents and sample have been loaded on the NextSeq and the 
sequencing run has begun, the multiplexed sample is washed over the flow cell 
where cDNA molecules with adaptors hybridize to an oligo lawn with 
complementary sequences. A DNA polymerase makes a compliment to the 
original cDNA molecule primed from the oligo attached to the flow cell, the 
double stranded cDNA is denatured, and the original cDNA molecule is washed 
away. The attached compliment binds a second oligo attached to the flow cell, 
and is copied by a DNA polymerase in a process called bridge amplification. The 
process is repeated many times over until a cluster of cDNA molecules grows 
that will be large enough for the sequencer to read. Fluorescently labeled dNTPs 
are washed over the flow cell where they incorporate into the growing DNA 
strand primed off the template attached to the flow cell. This process is used to 
identify the sequence of both the DNA library fragments made from the original 
samples and the nucleotide barcode ligated to that DNA that identifies which 
sample it comes from (Illumina, 2016). 
 BASIC PROTOCOL 4: RNA-Seq Bioinformatics
The analysis of RNA-Seq data can be done using a variety of open source or proprietary 
programs.  If you are using a Core Facility to do RNA-Seq they are also likely to be able to 
analyze the data for you or at least assist you in the basic steps to obtain the aligned datasets.  
We build the libraries and run the RNA-Seq ourselves and use the methods described below to 
analyze the data.
Software
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Software for Linux OS:
Bcl2fastq2 (Illumina, 2017a)
Software for Linux OS or Mac OS:
FASTX-Toolkit (Hannon_Lab, 2014)
TopHat2 (Trapnell et al., 2016)
Bowtie2 (Langmead, Kim, Charles, Wilks, & Antonescu, 2018)
Cufflinks (Trapnell et al., 2014)
Software for Linux OS, Mac OS, or Windows OS:
R (Gentleman et al., 2018)
RStudio (RStudio, 2018)
tidyr (Wickham & Henry, 2018)
dplyr (Wickham, François, Henry, & Müller, 2018)
ggplot2 (Wickham, Chang, et al., 2018)
Convert BCL files to FASTQ files
Illumina sequencers generate per cycle base call (BCL) files. However, most informatic 
programs take FASTQ or FASTA files as input. Bcl2fastq2 software is able to covert the files, as 
well as, demultiplex samples. A detailed user guide is available on Illumina’s website including 
system requirements for the software (Illumina, 2017b).
1. Create a sample sheet with sample names, numbers, and corresponding nucleotide 
barcodes. This is saved as a .csv in the following format:
[Data],,  
Sample_Name,Sample_ID,Index
Sample1,1,CGCTACAT
Sample2,2,AATCCAGC
Sample3,3,CGTCTAAC
Etc.
2. Run the blc2fastq2 in Terminal (denoted with $ hereafter) with the following options:
$ bcl2fastq --minimum-trimmed-read-length 0 --mask-short-adapter-reads 0 --no-lane-
splitting -o /output_folder -R run_folder --sample-sheet run_folder/SampleSheet.csv
Explanation:
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blc2fastq – calls the program.
minimum-trimmed-read-length – specifies a length to not trim if trimming adapters will 
result in a read of less than this length. In these cases, the adapter portion will be 
masked by replacing base calls with Ns. By specifying 0 we are telling the program to 
trim adapters no matter the remaining length of the read. Default is 35.
mask-short-adapter-reads – specifies a length of a read that if it falls below will be 
masked by Ns. By specifying 0 we are instructing the program not to do this. Default is 
22 (must be set equal or lower than minimum-trimmed-read-length).
no-lane-splitting – this option instructs the program to include all reads for each given 
sample in one file. Without this option the NextSeq will give four files for each sample, 
one for each of lanes 1-4. If the researcher is planning to upload FASTQs to Illumina’s 
basespace.com they should not call this option as basespace will only accept sample 
files that do have lanes split.
-o – specifies the output folder.
-R – specifies the run folder or where the BCL files are located.
--sample-sheet – points to where the sample sheet is located. 
Trim and filter FASTQ files
3. Trim the first 5 base calls and filter out low quality reads. FASTX-Toolkit tools can 
accomplish this with the following command:
$ for i in sample1 sample2 sample3 etc; do zcat $i_S1_R1_001.fastq.gz | fastx_trimmer 
-f 6 -v -Q33 | fastq_quality_filter -q 25 -p 80 -v -Q33 -z -o $i.fastq.gz; done
Explanation:
Commonly known as a “for loop”.
for i in sample1 sample2 sample3 etc – is a list of your samples to iterate over.
do X – could be any command. This command will then iterate over your list.
done – tells the command to stop.
$i – is the placeholder where the list of samples will be substituted in.
zcat – looks at a compressed file.
| – called a pipe, it sends information from first command to the next command.
fastx_trimmer -f 6 – this option says trim the first 5 base calls and keep everything from 6 
onward.
fastq_quality_filter -q 25 -p 80 – this option says only keep reads with a quality score of 
25 or higher on at least 80% of the base calls.
-z – is the option to compress output file.
-o – is the name of file or directory name/name of file.
Align FASTQ files to a reference genome
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We use TopHat2 (Kim et al., 2013; Trapnell, Pachter, & Salzberg, 2009) for alignment against 
GRCm38/mm10 UCSC. Useful links to reference genomes with prebuilt bowtie indexes and 
GTF transcript annotation files can be found here: 
http://ccb.jhu.edu/software/tophat/igenomes.shtml. A detailed protocol for TopHat has been 
published elsewhere (Trapnell et al., 2012). 
4. Use the following command for alignments:
$ for i in sample1 sample2 sample3 etc; do tophat2 -p 8 -G genes.gtf -o output_folder/$i 
Bowtie2Index/genome folder_with_fastqs/$i.fastq.gz; done 
explanation:
tophat2 – is a program that performs alignment.
-p 8 – specifies the number of CPU processors to use. Check your system information 
and set this at or below the total number of logical cores on the computer running the 
software. 
-G – points to directory and .gtf file. 
-o – points to output directory and /$i – is the placeholder for sample. 
Sequence/Bowtie2Index/genome – points to directory with index files. 
folder_with_fastqs/$i.fastq.gz – points to directory and fastq files. This is the actual 
sequencing data.
Quantify and compute differential gene expression
We use cuffdiff of cufflinks (Roberts, Trapnell, Donaghey, Rinn, & Pachter, 2011; Trapnell et al., 
2013; Trapnell et al., 2010) to compute differential gene expression. A detailed protocol has 
been published elsewhere (Trapnell et al., 2012).
5.  Use the following command to calculate differential expression:
$ cuffdiff -p 8 -no-update-check -o output_folder -b Bowtie2Index/genome.fa -u genes.gtf 
-L condition1,condition2 
\./tophat_folder/condition1_S1/accepted_hits.bam,./tophat_folder/condition1_S2/accepte
d_hits.bam,tophat_folder/condition1_S3/accepted_hits.bam,etc 
\./tophat_folder/condition2_S1/accepted_hits.bam,./tophat_folder/condition2_S2/accepte
d_hits.bam,tophat_folder/condition2_S3/accepted_hits.bam,etc
explanation:
cuffdiff – is a program to test for differential gene expression.
-p 8 – this option specifies how many CPU processors to use. 
-no-update-check – use this option as the software is no longer being updated.
-o – points to folder you want your results saved in.
-L – name of your two conditions e.g. control, treatment or input, IP. 
-b – this option corrects for RNA-seq read coverage bias (Roberts et al., 2011). 
-u – this option performs an initial estimate to improve accuracy when weighting reads 
mapping to multiple locations.
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We run cuffdiff first on inputs vs IPs within conditions and then IP vs IP across 
conditions. In some cases, one may only be asking what is unique about these 
cells within this tissue. In which case one would only compare input to IP. It is 
important to note that genes that are expressed widely in the total population of 
neurons will not show up as differentially expressed even if they are expressed in 
the targeted neuron population.  The difference between IP and input will only be 
significant when a transcript is preferentially expressed in the HA-tagged neuron 
population. 
Visualize results
Use R within RStudio to visualize your results utilizing tidyr, dplyr, and ggplot2 packages 
(Wickham, 2016). 
6. If necessary, install packages.
> install.packages(“tidyr”)
> install.packages(“dplyr”)
> install.packages(“ggplot2”)
Load packages.
> load(tidyr)
> load(dplyr)
> load(ggplot2)
7. Import output files “gene_exp.diff” and “genes.read_group_tracking” from cuffdiff and 
save them as an object. The names of the objects are arbitrary; however, good object 
names should be short but descriptive. Below the first named object “cdstats_aipvn” 
describes cuffdiff statistical output for condition A, IP vs input. The example below 
assumes the three cuffdiff output folders are saved in the working directory the R-project 
is started in. 
> cdstats_aipvn <- read.delim(“cuffdiff_A_IP_vs_N/gene_exp.diff”)
> cdstats_bipvn <- read.delim(“cuffdiff_B_IP_vs_N/gene_exp.diff”)
> cdstats_avb <- read.delim(“cuffdiff_A_vs_B/gene_exp.diff”)
> cdfpkms <- read.delim(“cuffdiff_A_vs_B/genes.read_group_tracking”)
8. Below are three examples of creating a list of genes expressed at certain thresholds in 
the IP relative to the input in condition A. 
> A_2fold <- filter(cdstats_aipvn, q_value < 0.05, log2.fold_change. > 1, value_2 > 5) 
%>% select(“test_id”)
> A_1fold <- filter(cdstats_aipvn, log2.fold_change. > 0, value_2 > 5) %>% 
select(“test_id”)
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> A_half_fold <- anti_join(dr1stats, filter(dr1stats, log2.fold_change. < -1, q_value < 
0.05), by = "test_id") %>% filter(value_2 > 5) %>% select("test_id")
9. Filter condition B the same way, then join the 2 lists to create a list of genes that could 
be important in either condition A or condition B.
> AB_2fold <- full_join(A_2fold, B_2fold)
10. Now the new list of genes that could be important in either condition can be used to filter 
for genes that one would want to compare across conditions.
> AIP_vs_BIP <- inner_join(AB_2fold, cdstats_avb, by = “test_id”)
Cuffdiff includes a column in the output file gene_exp.diff labeled “significant” that 
can be useful while graphing data assigning different colors to the binomial 
values (“yes” or “no”). However, we find it useful to append additional columns 
that can specify other criteria, for example, both statistically significant and 
meaningfully different. 
11. In the example below, we are using 2-fold again.
> temp1 <- filter(AIP_vs_BIP, abs(log2.fold_change.) > 1, q_value < 0.05) %>% 
mutate(DE = “yes”)
> temp2 <- anti_join(AIP_vs_BIP, temp1, by = “test_id”) %>% mutate(DE = “no”)
> AIP_vs_BIP2 <- full_join(temp1, temp2)
12. A common graph made with RNA-Seq data is a volcano plot. This plots p-value vs fold 
change, usually both have been log transformed. One can now use the newly created 
“DE” column to highlight genes that are both 2-fold different and statistically different.
> volcplot <- ggplot2(AIP_vs_BIP2, aes(log2.fold_change., -log(q_value), color = DE) + 
geom_point(alpha = 0.5) 
By saving the plot as an object (“volcplot”) it is easy to call up the object and 
modify various aspects experimenting with different options until one is satisfied 
with the plot’s appearance. Below we have modified the default colors of the 
points to black and red, drawn a horizontal line where the corrected p-value is 
0.05, drawn lines indicating where the fold change is 2-fold, and selected a 
different theme (Figure 2A). We like the way theme_classic and theme_bw look 
but this is purely a matter of preference. 
> volcplot + scale_color_manual(values=c("black", "red")) + geom_hline(yintercept = -
log(0.05)) + geom_vline(xintercept = c(-1,1)) + theme_bw()
Another common plot one could make is a scatter plot, plotting log transformed values 
for a list of genes with condition A on one axis and condition B on the other. 
Page 19 of 56
John Wiley & Sons
Current Protocols
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
> scatplot <- ggplot(AIP_vs_BIP2, aes(log2(value_1), log2(value_2), color = DE)) + 
geom_point(alpha = 0.3) +
scale_color_manual(values = c("black", "red")) +
theme_classic()
One can relabel the axis and give the plot a title if they wish (Figure 2B). 
> scatplot + labs(x = "A log2(FPKM)", y = "B log2(FPKM)", title = "A vs B") +
theme(plot.title = element_text(hjust = 0.5)) +
theme(text = element_text(size = 20))
Finally, one may wish to plot individual genes of interest:
Boxplot
> box_geneA <- filter(cdfpkm, tracking_id == "GeneA") %>%
ggplot(aes(condition, FPKM, fill = condition)) + 
geom_boxplot() +
theme_bw() +
theme(legend.position="none") +
scale_fill_manual(values = c("white", "red")) +
ylim(0,NA)
Add a title using labs, center justify using hjust, and change the font size with element 
text (Figure 2C).
> box_geneA + labs(title = “GeneA”) +
theme(plot.title = element_text(hjust = 0.5)) +
theme(text = element_text(size = 20))
Bar chart 
> bar_geneA <- filter(cdfpkm, tracking_id == "GeneA") %>%
ggplot(aes(condition,FPKM)) + 
stat_summary(fun.data="mean_se", geom="bar", color="black", aes(fill=condition)) + 
stat_summary(fun.data="mean_se", geom="errorbar", width=0.3, color="black") + 
theme_bw() +
theme(legend.position="none") +
scale_fill_manual(values = c("white", "red")) +
labs(title = “GeneA”) +
theme(plot.title = element_text(hjust = 0.5)) + 
theme(text = element_text(size = 20))
Add in individual data points for greater data reporting transparency (Figure 2D).
> bar_geneA + geom_point(size = 3) 
[*Copy Editor – Insert Figure 2 here]
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REAGENTS AND SOLUTIONS
Tris base (Sigma; cat. No. T1503). 
 Prepare a 1.5M pH 7.4 stock solution (pH with HCL) and store at 4ºC
KCl (Sigma; cat. No. P9541). 
 Prepare a 1M stock solution and store at 4ºC
MgCl2 (Sigma; cat. No. 63068). 
 Prepare a 1M stock solution and store at 4ºC
Nonidet P-40 Substitute, 10% (w/v) solution (Roche, cat. No. 11 332 473 001)
Cycloheximide (Sigma, cat. No. C7698).
 Prepare a 5mg/ml stock solution and store at -20ºC.
Heparin (Sigma; cat. No. H3393). 
 Prepare a 100 mg/ml stock solution and store at 4ºC.
Phosphate buffered saline (PBS), tablets (Millipore, cat. No. 524650-1EA). 
 Prepare at 1x with water.
Paraformaldehyde (Sigma cat. No. P6148). 
 Prepare a 4% solution in PBS 1x. Adjust pH to 7.4. Prepare fresh and store at 4ºC.
Sucrose (Sigma cat. No. 84097). 
 Prepare a 30% solution in PBS 1x pH 7.4. Store at 4ºC.
Sodium Azide (Sigma, cat. No. S2002). 
 Prepare a 0.02% solution in PBS pH 7.4
Triton X-100 (Millipore, cat. No. 648466). 
 Prepare a 0.2% solution in PBS pH 7.4.
 
Homogenization buffer: 
 50 mM Tris pH7.5
 100 mM KCl 
 12 mM MgCl2
 1% Nonidet P-40 
 1 mM DTT 
 200 U/mL Promega RNasin 
 1 mg/mL heparin 
 100 ug/mL cycloheximide 
 protease inhibitor mixture (1x)
Optional: The addition of 1% sodium deoxycholate (DOC) to the homogenization buffer 
reduces some of the non-specific background.  We have shown that DOC does not 
significantly reduce the purification of specific polysomes and suggest testing it in your 
experiments. 
Homogenization buffer is prepared by adding defined volumes of stock solutions for Tris 
(1.5M pH 7.4), KCl (1M) and MgCl2 (1M) to nuclease free water to achieve the final 
concentrations described above in the desired volume. Right before homogenization, 
buffer is supplemented with DTT, protease inhibitors, RNasin, heparin and 
cycloheximide.
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High salt buffer: 
 50 mM Tris pH 7.5 
 300 mM KCl 
 12 mM MgCl2 
 1% Nonidet P-40 
 0.5 mM DTT
 100 ug/mL cycloheximide 
Prepare using Tris, KCl and MgCl2 stock solutions. Add DTT and Cycloheximide right 
before using. 
COMMENTARY
Background Information
It has been a little over 10 years since the first development of cell-type specific 
ribosome tagging strategies that permitted the analysis of a cell's translatome (the mRNAs 
engaged on polyribosomes) (Heiman et al., 2008).  The original technique utilized BAC 
transgenic mice that were engineered to express a GFP-tagged 60S ribosomal subunit protein 
(Rpl10a) behind a cell type specific promoter.  Antibodies directed against GFP were used to 
immunoprecipitate the tagged polyribosomes from which mRNA could then be isolated and 
analyzed by qRT-PCR, microarray, or RNA-Seq. This approach required the generation of novel 
BAC transgenic mice specific for each cell type and did not take advantage of the many tissue 
specific Cre recombinase mouse lines that were already developed.  
We developed an alternative approach described in this RiboTag protocol in which an 
HA-tagged ribosomal protein (Rpl22) is conditionally expressed from the mouse genome by the 
action of Cre recombinase (Sanz et al., 2009).  This approach takes advantage of the constantly 
expanding diversity of cell type specific Cre recombinase expressing mouse lines.  Both 
approaches suffer from the same limitation: the investigator must have already identified a gene 
promoter that is specific for the cell type of interest.  Although it is unlikely that subtypes of 
neurons can be uniquely defined by the expression of a single Cre recombinase transgene, the 
ribosome tagging strategies have facilitated analysis of the mRNAs engaged with 
polyribosomes in many neuronal cell types and can also be used to study the regulation of 
specific genes in vivo.
One alternative approach that has rapidly been adopted by neuroscientists is single cell 
transcript analysis by direct RNA-Seq.  A single anatomical structure such as the arcuate 
nucleus of the hypothalamus is dissociated into single cells, the transcripts from each cell are 
uniquely barcoded, and the RNA is analyzed by RNA-Seq.  Clustering analysis is used to 
identify unique cell types including neurons and glial cells, and then the neurons can be further 
clustered into discreet sub-types based on their transcript phenotype.  This unbiased approach 
is very useful to explore the full range of neurons in a specific anatomical location and will 
rapidly leading to transcriptome phenotypes for all of the neurons and glial cells in a mouse 
brain.  One limitation of this approach is that relatively non-abundant transcripts escape 
detection due to the large number of different cell types being sequenced en masse. Another 
limitation is that the techniques that must be used to obtain single cells, especially starting with 
the brain, can cause alterations in gene expression (e.g. induction of immediate early genes) 
(Moffitt et al., 2018; van den Brink et al., 2017) and may also lose transcripts that are 
sequestered in neuronal processes where they are also likely to be under translational control.  
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The ribosome capture approaches like RiboTag will only isolate mRNAs that have ribosomes 
bound to them and are expected to be actively translated into protein. 
Critical Parameters and Troubleshooting
1.  Cell type Specificity:  The specificity of the RiboTag analysis depends on the 
specificity of the Cre recombinase transgenic mouse line and every effort should be made to 
verify that the Cre transgenic drives expression of Rpl22-HA in the appropriate cell type and 
does not give rise to ectopic expression in other tissues that would interfere with the analysis.  It 
is important to check that recombination of the RiboTag allele is not occurring during early 
development giving rise to mice with variable expression in many other cell types.  This can be 
done by analyzing expression of Rpl22-HA by immunohistochemistry and comparing it to a 
marker for the cells of interest as described in Basic Protocol 2.  We also routinely screen for 
RiboTag recombination in tail DNA during genotyping as described in the Support Protocol 1. 
This will help identify mice that have undergone recombination of the RiboTag allele during early 
development and they should be removed from the cohort to be studied as adults. 
2. Background and Controls:  When we analyze the RNA from a RiboTag experiment 
we find that the immunoprecipitated polysomes still contain mRNAs from cells that are not 
expressing Cre recombinase and Rpl22-HA (e.g. glial cells).  These transcripts are depleted in 
the IP (IP/input ratios <0.3) but since some are abundantly expressed, they will still appear at 
significant levels in the IP.  As described in Basic Protocol 4 we advise analyzing both the input 
and IP RNA and then considering whether to filter out background gene transcripts that are 
depleted.  In some of our experiments we are interested in gene transcripts which are enriched in 
the cell type being studied and help define a unique phenotype for those neurons.  In addition to 
the background of depleted mRNAs seen in the IP we have observed that the IP may also contain 
enriched transcripts from genes that are clearly not expressed in the cell type of interest. These 
false positives can confound the data and we suggest doing a control IP experiment starting with 
equivalent tissue from a mouse that does not express RiboTag.  Transcripts that enrich in the 
absence of Rpl22-HA expression are artifacts of the technique and should be eliminated from the 
specific transcripts isolated when Rpl22-HA is expressed. As described in the protocol we have 
recently been able to reduce the capture of these artifactually enriched genes by including an 
ionic detergent, sodium deoxycholate, in the initial homogenization buffer. 
3.  Anticipated Results and Statistical Analysis:  Each tissue homogenate yields two 
RNA-Seq libraries, an input and an IP.  We typically run 8-16 RNA-Seq libraries on a NextSeq 
500/550 flow cell and expect to have 25-50 million aligned reads for each library.  Statistical 
analysis of this data requires at least 3 replicates making these experiments quite expensive in 
terms of reagents.  If one is trying to phenotype the cells the first analysis would be to determine 
all of the expressed genes comparing IP to input and then to rank those transcripts by the ratio 
of IP to input.  Transcripts that come up as enriched in a control IP from a mouse that does not 
express RiboTag should be removed from this transcript phenotype.  If the animals have been 
treated with pharmacologic agents or exposed to physiological challenges, transcripts that 
change between samples can be identified and statistically analyzed as described in Basic 
Protocol 4.  It is very helpful to correlate the specific transcripts that are enriched in the Cre-
expressing cells with the in situ hybridization results from the Allen Mouse Brain Atlas.  
Specificity can also be confirmed using RNAscope (Advanced Cell Diagnostics) to colocalize 
transcripts in the anatomical region of interest.  One can also confirm results by qRT-PCR 
starting with either the original RNA samples or qPCR with the DNA libraries.  
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The RiboTag approach is ideally suited to studying the dynamic regulation of genes in a 
specific neuronal population.  Transcripts can be induced within minutes after the addition of 
hormones and drugs or changes in nutritional or environmental conditions.  When an mRNA is 
specifically induced in the RiboTag targeted cell but constitutively expressed in neighboring 
cells, the level of transcripts in the IP will increase and the enrichment (IP/input) will also 
increase. If a gene like Fos is induced in all of the cells in the tissue being analyzed, then you 
will see an increase in IP transcripts for Fos but no change in enrichment.
Translational control:  RiboTag techniques will only isolate mRNAs that have 
ribosomes bound and this implies that these mRNAs are being actively translated.  However, it 
is important to consider that RiboTag is not going to be very sensitive to how many ribosomes 
are engaged on a particular mRNA.  For example, if an mRNA is under translational control and 
only has 2-3 ribosomes in the repressed state and 12 or more ribosomes when induced, the 
efficiency of immunoprecipitation may not change enough to be a quantitative indicator of 
translational activity.  Ribosomes may also remain attached to mRNAs even when elongation 
and active synthesis of protein is repressed.
4.  Time Considerations:  One of the advantages of the RiboTag procedure is that 
once the animals are obtained either by mating RiboTag mice with a specific Cre driver 
transgenic or stereotaxically injecting AAV-RiboTag virus and waiting for RiboTag expression, 
the immunoprecipitation of specific RNA can be completed in a day.  Production of DNA 
libraries for RNA-Seq and DNA sequencing can be completed in a few more days.  The most 
time-consuming step is the analysis of results and this depends on what questions are being 
asked and the number of different tissues and conditions being studied.  
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FIGURE LEGENDS
Figure 1.  Cartoon comparing the RiboTag mouse and AAV-DIO-RiboTag approaches
On the left side, the Rpl22 locus was modified by homologous recombination to insert LoxP 
sites on either end of the last exon (Ex4) of the Rpl22 gene and a duplicated Ex4 with an HA tag 
was inserted downstream.  The CRE-Driver mouse removes the WT Ex4 sequence in specific 
cells and the transcript now splices in Ex4-HA (shown in green).  Polyribosomes from cells 
expressing the Ex4-HA are recovered from a lysate by immunoprecipitation (IP) with an 
antibody directed against HA and magnetic beads coated with an artificial Protein A/G peptide.  
RNA is isolated from the IP polyribosomes and RNA is also isolated from the lysate.  Gene 
expression analysis is done by RNA-Seq. On the right side the DIO-RiboTag viral vector is 
shown schematically.  In the presence of Cre-recombinase the Rpl22-HA-IRES-YFP cassette is 
flipped and locked in the ON configuration so that the eIF1a promoter now drives expression of 
Rpl22-HA in specific cells.  RNA is isolated from the IP and compared with the input.
Figure 2.  Example plots of hypothetical RNA Seq data. A, Volcano plot of data with log 
base 2 transformed fold change (condition A vs condition B) plotted on the x axis and negative 
natural log transformed corrected p-value (q-value) plotted on the y axis. The solid horizontal 
line denotes where q-value is equal to 0.05. The two solid vertical lines denote where fold 
change is equal to 2 (or -2). Data points are colored red if they are both 2-fold different and have 
a q-value less than 0.05; otherwise they are black. B, Scatter plot of data with log2 transformed 
fragments per kilobase million (FPKM) plotted on the x axis for condition A and the y axis for 
condition B.  As in A data points are colored red if they are both 2-fold different and have a q-
value less than 0.05; otherwise they are black. C, Box plots for Gene A for condition A and B. 
FPKM are plotted on the y axis with the two conditions represented side by side on the x axis. 
D, Bar graphs denoting mean plus or minus standard error of the mean (SEM) for Gene A for 
condition A and B. FPKM are plotted on the y axis with the two conditions represented side by 
side on the x axis. Individual data points are superimposed on top of the bars for greater data 
reporting transparency. DE, differentially expressed. 
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Abstract:
Ribosome tagging has become a very useful in vivo approach for analyzing gene expression 
and mRNA translation in specific cell types that are difficult and time consuming to isolate by 
conventional methods.  The approach is based on selectively expressing an HA-tagged 
ribosomal protein in a target cell type and then using antibodies against HA to purify the 
polysomes and associated mRNAs from the target cell.  The original approach makes use of a 
mouse line (RiboTag) harboring a modified allele of Rpl22 (Rpl22-HA) that is induced by the 
action of Cre recombinase.  The Rpl22-HA gene can also be introduced into the animal by 
stereotaxic injections of an AAV-DIO-Rpl22-HA that is then activated in Cre-expressing cells.  
Both methods for tagging ribosomes facilitate the immunoprecipitation of ribosome bound 
mRNAs and their analysis by qRT-PCR or RNA-Seq.  This protocol will discuss the technical 
procedures and describe important considerations relevant to the analysis of the data.
Introduction:
The analysis of gene expression provides a description of a cell's potential functions and its 
response to extracellular signals.  However, when researchers attempt to analyze gene 
expression in vivo they are confronted with the problem that all tissues contain a diverse array 
of different cell types with unique functions.  Efforts to isolate a specific cell type for analysis 
based on sorting techniques can be successful but these additional manipulations are both time 
consuming and have been shown to alter transcription (Haimon et al., 2018).  The brain is a 
particularly challenging tissue in which to quantitate gene expression and translation. A typical 
mouse brain is made up of around 75 million neurons, 23 million glial cells, 7 million endothelial 
cells and several million other miscellaneous cell types (Williams, 2000).  Neurons are 
extremely diverse in terms of their expression of various neurotransmitters, neuropeptides, and 
receptors and typically these neurons are anatomically intermingled making them very difficult to 
separate for molecular analysis.  In situ analysis of mRNA expression has been very useful in 
identifying the overall anatomical distribution of neurons expressing specific genes and the Allen 
Brain Institute has assembled a comprehensive database for both the mouse and human brain 
which is very useful.  However, anatomical localization cannot define specific neuronal cell 
types.  Characterization of the mRNA expression phenotype of specific neurons has progressed 
with the development of ribosome-tagging approaches, cell sorting based on promoter specific 
expression of fluorescent marker proteins, and single-cell RNA-Seq.  Each approach has 
advantages and disadvantages. In this protocol we describe a ribosome-tagging approach 
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(RiboTag) which our lab developed (Sanz et al., 2009) and discuss the application of this 
approach to the analysis of polyribosome associated mRNA transcripts in specific populations of 
neurons.  The RiboTag approach takes advantage of the hundreds of specific promoter-driven 
Cre recombinase transgenics currently available (Jackson Laboratories has more than 480 
lines) and others are being added at a rapid pace. 
There are two basic approaches involving the use of RiboTag as diagrammed in Figure 1 and 
each has advantages and disadvantages.  In the first approach we use a RiboTag mouse line in 
which the 60S ribosomal gene, Rpl22, was modified so that in the presence of Cre recombinase 
the last exon of Rpl22 will be replaced with an HA-tagged exon effectively labeling the cell's 
polyribosomes so that they can be isolated by immunoprecipitation.  These RiboTag mice are 
crossed to a Cre recombinase driver mouse line and the double heterozygotes are used for 
analysis.  Immunoprecipitation of polyribosomes from neuronal tissue purifies only the 
polysomes that are tagged in the Cre-expressing cells.  The mRNA from these polysomes is 
isolated and the transcripts analyzed by qRT-PCR or RNA-Seq. The second approach utilizes a 
Rpl22-HA construct in a flex or DIO virus (AAV) flanked by two different sets of loxP sites (Sanz 
et al., 2015).  When the AAV-DIO-RiboTag is injected into a specific anatomical region of the 
brain of an adult mouse the Rpl22-HA is only expressed in the neurons that are actively 
expressing Cre recombinase and also infected by the AAV.  After waiting several weeks for the 
Rpl22-HA to be expressed and incorporated into polyribosomes, tissue samples are isolated 
and used to immunoprecipitate HA-tagged polyribosomes followed by qRT-PCR or RNA-Seq.  
The viral approach requires accurate stereotaxic injections of virus and is more labor intensive 
but has the advantage that only adult neurons that still express the Cre transgenic will be 
targeted.  The direct cross of RiboTag mice with Cre driver mice is easier to do but has the 
potential disadvantage that the Rpl22-HA could continue to be expressed in neurons that have 
differentiated from a progenitor population that expressed Cre recombinase at an earlier stage 
during development.  One can take advantage of this difference by comparing results from the 
same brain region using the RiboTag mouse and the RiboTag virus using the same Cre driver 
transgenic.  We have used this approach to demonstrate that embryonic Pomc-expressing 
progenitor neurons differentiate into both Agrp and Kiss1 expressing neurons in the adult 
arcuate nucleus of the hypothalamus (Sanz et al., 2015).  
[*Copy Editor – place Figure 1 here]
Basic Protocol 1 outlined below describes our methods in detail using the RiboTag mouse 
crossed with a specific Cre-recombinase expressing transgenic mouse to isolate polyribosomes 
by immunoprecipitation from brain homogenates and then further isolate RNA from both the 
input (original homogenate) and the immunoprecipitated (IP) polysomes.  Alternative Protocol 
1 describes the viral approach using stereotaxic injection of AAV-DIO-RiboTag into adult Cre-
recombinase expressing mouse brain to avoid developmental activation of RiboTag expression.  
In Support Protocol 1 we describe the breeding and genotyping of RiboTag mice and in 
Support Protocol 2 we describe the analysis of captured RNA using qRT-PCR.  Basic 
Protocol 2 discusses the use of RiboTag mice crossed with a specific Cre transgenic line to 
identify the anatomical localization of RiboTag expression by immunohistochemistry.  In Basic 
Protocol 3 we describe the current approach our lab is using to produce DNA libraries for RNA-
Seq. Basic Protocol 4 describes the bioinformatic tools that we are using to analyze the RNA-
Seq data.  In the Commentary we will provide a discussion of these methods and identify some 
of the most critical parameters and potential trouble spots.
BASIC PROTOCOL 1
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The RiboTag Assay
This approach has been described and updated in several publications from our laboratory 
(Quintana et al., 2012; Sanz et al., 2013; Sanz et al., 2015; Sanz et al., 2009) and is shown 
schematically in Figure 1. We have now introduced modifications that improve the efficiency of 
the immunocapture and therefore increase the RNA yields obtained in the immunoprecipitates. 
These modifications include using an indirect method for the immunocapture of HA-tagged 
polysomes (instead of the direct immunoprecipitation procedure described in the original 
publication) and using Protein A/G beads with a higher binding capacity for IgGs.
Materials:
Mice:
RiboTag mouse line (JAX stock No. 011029)
Cre-driver mouse line of choice
Equipment:
Large sharp surgical scissors (FST cat No. 14001-14)
Small extra fine scissors (FST cat No. 14084-08)
Spatula (FST cat No. 10091-12) 
Harris Uni-Core (Electron Microscopy Sciences cat No. 69036)
Razor blades (Electron Microscopy Sciences cat No. 71960) 
Mouse brain matrix (Electron Microscopy Sciences cat No. 69022)
Glass Dounce homogenizers (2ml or 7ml) (Sigma cat. No. 8938 or 9063)
Refrigerated centrifuge (Eppendorf; cat. No. 5417R) with rotor for 1.5 ml microcentrifuge tubes.
Microcentrifuge tubes (Axygen; MCT-175-C)
10 ul ART Barrier pipette tips (Thermo Fisher Sci.; cat. No. 2140-HR)
20 ul ART Barrier pipette tips (Thermo Fisher Sci.; cat. No. 2149-HR)
200 ul ART Barrier pipette tips (Thermo Fisher Sci.; cat. No. 2069-HR)
1000 ul ART Barrier pipette tips (Thermo Fisher Sci.; cat. No. 2179-HR)
Microtube magnetic stand (Thermo Fisher Sci.; cat. No. 12320D)
Microtube rotator (Thermo Fisher Sci.; cat No. 88881002)
Nanodop One (Thermo Fisher Sci.; cat. No. 13-400-518)
Fluorescence microplate reader (for Quant-iT Ribogreen RNA assays)
2100 Bioanalyzer Instrument (Agilent; cat. No. G2939BA)
Materials:
Sterile water for irrigation (Baxter, cat. No. 2F7114)
1M DTT, 10X 0.5ml ampules (Sigma; cat. No. 646563-10X 0.5ml). Aliquot open ampules and 
store at -80ºC
Protease inhibitor cocktail (Sigma, cat. No. P8340-5ml). Aliquot and store at -20C
RNAsin (40U/ul) (Promega, cat. No. N2115)
b-mercaptoethanol (Bio-Rad; cat. No.1610710
Pierce protein A/G magnetic beads (Thermo Fisher Sci.; cat. No. 88803)
Covance Anti-HA.11 Epitope Tag Antibody (BioLegend; cat. No. MMS-101R). Aliquot and store 
at -20ºC
RNeasy Mini Kit (Qiagen; cat. No. 74104) or RNeasy Micro kit (Qiagen; cat. No. 74004)
Quant-iT RiboGreen RNA Assay kit (Thermo Fisher Sci.; cat. No. R11490)
RNA 6000 Nano kit or RNA 6000 Pico kit (Agilent; cat. No. G2939BA, 5067-1511 or 5067-1513)
Ethanol (200 proof)
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Protocol steps:
Harvest tissue
1. Euthanize mice using IACUC approved procedures such as carbon dioxide inhalation
2. Decapitate mice using large sharp surgical scissors 
3. Make a midline incision in the skin and expose the skull
4. Using small scissors and a spatula remove the skull
5. Lift the brain out of the skull and use a spatula to section the optic and other cranial 
nerves
6. Place the brain in a cold block or brain matrix for further dissection. Sampling tools such 
as Harris Uni-cores can be used to punch the area of interest.
Lysate preparation
7. Clean Dounce tissue grinder and dissection tools and rinse thoroughly with RNase-free 
water (sterile water for irrigation can be used at this step). Air dry and place Dounce 
homogenizer on ice.
8. Prepare the homogenization buffer as described in the Reagents and Solutions section 
and keep on ice.
9. Dissect the tissue containing the cell type of interest. Specific areas or whole tissue can 
be used in this approach. 
A brain matrix and sampling tools such as brain punches or Harris Uni-Cores can be 
used to precisely dissect the area of interest. Dissected tissue or punches of the area 
of interest can either be flash-frozen in liquid nitrogen right after dissection and 
stored at -80ºC for months or processed fresh.  
10. Place the tissue in the ice-cold Dounce homogenizer vessel containing a defined volume 
of pre-chilled homogenization buffer and homogenize using 40 strokes of the loose-
fitting pestle (type A pestle), followed by 40 more strokes with the tight-fitting pestle (type  
B pestle). 
We typically use a 2-5% w/v ratio (for areas with a limited number of cells from the 
cell type of interest a pool of punches of the same area from different animals can be 
used to increase RNA yields). For small amounts of tissue (10-50mg tissue) we use 
the 2 ml Dounce and for 50-300mg we use the 7 ml Dounce.
11. After homogenization, transfer lysate to a microtube on ice.
12. Clear the lysate at 10,000 x g for 10 min at 4ºC using a refrigerated centrifuge.
13. Transfer the post-mitochondrial supernatant to a pre-chilled microcentrifuge tube on ice. 
Discard resulting pellet. 
14. Take a small aliquot of the cleared lysate (40-80 ul) and store it at -80ºC for subsequent 
Input analysis.
Immunoprecipitation
15. Add 4 ul of the anti-Hemagglutinin (HA) antibody (Covance Anti-HA.11 Epitope Tag 
Antibody) to 800 ul of the remaining cleared lysate and incubate for 4 hours at 4ºC in a 
microtube rotator with gentle mixing (end-over-end).
16. Prepare the magnetic protein A/G beads: 
 Thoroughly resuspend the beads by repeated inversion or gentle vortexing.
  Place a microtube magnetic stand on ice and transfer 200 ul of the resuspended 
beads to a clean microcentrifuge tube. 
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 Place the tube into the magnetic stand on ice to collect the beads and remove 
and discard the storage buffer. 
 Add 400 ul of homogenization buffer and rotate end-over-end for 5 min to wash 
the beads. 
 Collect the beads with the magnetic stand, discard buffer.
17. Add the cleared lysate with the antibody to the beads. Incubate samples overnight at 
4ºC in a tube rotator with gentle end-over-end mixing. 
18. Next day, prepare the high salt buffer as described in the Reagents and Solutions 
section. Keep on ice.
a. Place samples into the magnetic stand on ice and remove supernatant 
(supernatant from the immunoprecipitation can be discarded or saved at -80ºC 
for subsequent analysis). 
Leave tubes in the magnet for at least one minute to collect all the beads 
against the side of the tube. 
19. With the tubes on the stand, add 800 ul of high salt buffer (Reagents and Solutions) to 
remove non-specific binding from the immunoprecipitate (IP). Transfer tubes to the 
rotator and wash the IP with gentle end-over-end mixing for 5 min at 4ºC. 
20. Place samples into the magnetic stand on ice and remove supernatant
21. Repeat high salt washes two more times with the same volume of high salt buffer for 5 
min each, for a total of three washes.
22. Resuspend beads in 800 ul of high salt buffer, mix on rotator for 5 min and transfer 
beads and buffer to a clean tube.
This step helps remove any RNA or polyribosomes that might be sticking to the 
original tube.
23. Place tubes on the magnetic stand for at least 1 min, carefully remove all high salt buffer 
24. Add 350 ul of RLT buffer from the Qiagen’s RNeasy extraction kit (mini or micro) 
supplemented with -mercaptoethanol (provided with the kit). 
25. Remove tubes from stand and vortex samples for 30 seconds at RT. 
At this step samples can be stored at -80ºC for subsequent RNA extraction or 
processed through the RNA extraction procedure.
RNA extraction 
26. Place tubes containing IPs in RLT buffer (from Qiagen kit) into the magnetic stand for 1 
min at RT to allow beads to be collected against the side of the tube 
27. Transfer the clear RLT buffer containing RNA to a new microcentrifuge tube. 
28. Proceed with RNA isolation with DNAse digestion following Qiagen's RNeasy extraction 
kit directions. 
29. To extract RNA from the Inputs (Step 6), bring input sample to 350 ul with RLT buffer 
supplemented with -mercaptoethanol, vortex extensively and proceed to RNA 
extraction as described for IPs. 
RNA extraction using column-based kits should be performed at RT. However, 
eluted RNA should be kept on ice at all times. For long term storage, RNA is 
safely kept at -80ºC for years. Whenever working with isolated RNA, always wear 
gloves to minimize RNase contamination, decontaminate working surfaces and 
use clean nuclease-free tubes and barrier pipette tips.
30. Quantitate RNA using Quant-iT RiboGreen RNA Reagent (Thermo Fisher) or a 
Nanodrop-One (Thermo Fischer Sci) following the manufacturer's protocols.
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If very low levels of RNA are expected (less than 2 ng/ul) the samples can be 
accurately quantitated by doing qRT-PCR using a house keeping gene such as 
Actb and comparing the results to known standard RNA solutions prepared with 
input RNA from the same tissue as detailed in Support Protocol 2.
31. Analyze RNA integrity on an Agilent 2100 Bioanalyzer system with the associated RNA 
6000 nano and pico kits (chose nano chips for samples 5-500 ng/ul, for samples with 
RNA concentrations < 5 ng/ul (down to 50 pg/ul) the pico chips should be used). Follow 
manufacturer’s directions.
Since most of the RNA isolated in Inputs and IPs is rRNA, the quality of mRNA is 
indirectly estimated by assessing the integrity of rRNA. A measure of RNA 
quality, the RNA integrity number (RIN), is also calculated by the software using 
an algorithm that assesses the electrophoretic traces of each sample. A RIN 
value of 7-10 indicates high quality RNA but RNA-Seq libraries can still be made 
and successfully analyzed starting with partially degraded RNA.
ALTERNATE PROTOCOL 1
Messenger RNA profiling using the RiboTag viral vector
To overcome the limitations associated with developmental activation of Cre 
recombinase transgenes and allow cell type-specific mRNA profiling of adult cells using 
Cre-Driver lines, we have developed a Cre-dependent RiboTag viral vector based on 
AAV1 (AAV1-DIO-RiboTag) (Sanz et al., 2015), where RiboTag expression is dependent 
on the activity of the promoter driving Cre recombinase expression in adult mice. This 
viral vector was created by inserting the cDNA of the mouse ribosomal protein Rpl22 
gene fused to three hemagglutinin (HA) sequences (Rpl22 · 3HA), into a double-floxed 
inverse open reading frame (DIO) AAV construct. For easy visualization of transduced 
cells, this construct also contains an IRES sequence (IRES2) followed by the YFP 
coding sequence as shown in Figure 1.
Materials:
Mice:
Cre-driver mouse line of choice.
Reagents:
RiboTag viral vector (AAV1-DIO-RPL22HA-IRES-YFP). Available upon request from authors
Equipment:
Stereotaxic apparatus with microsyringe pump (e.g. from World Precision Instruments)
Injection syringe (e.g. 5 ul Hamilton syringe)
Surgical tools 
Protocol steps:
1. Define stereotaxic coordinates by locating the injection target in a mouse brain atlas 
such as the Paxinos and Franklin’s “the Mouse Brain in Stereotaxic Coordinates” 
(Paxinos & Franklin, 2013) or the Allen institute for Brain Science’s “Adult Mouse Brain 
Reference Atlas” (Dong)
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2. Inject 0.2 to 0.5 ul of a RiboTag viral vector preparation (7 x 1011 viral genomes/ml) at 
the target site using the defined coordinates. 
Follow a stereotaxic injection protocol such as (Gore, Soden, & Zweifel, 2013). 
When targeting bilateral structures, inject each side. Injection volumes can be 
adjusted to the targeted area, or multiple injections performed to cover larger 
areas. Injecting different mice using the same coordinates and pooling the 
targeted areas after dissection helps correct for variability resulting from 
stereotaxic viral vector injections.
3. Allow at least 2 weeks for the viral vector to express Rpl22-HA. For RiboTag assays, 
good results are obtained when sacrificing animals at least 3 weeks after injections to 
allow for robust incorporation of Rpl22-HA into polyribosomes. 
4. Perform RiboTag immunoprecipitations as described in Basic Protocol 1
All surgical procedures should be performed in accordance with protocols approved by your 
Institutional Animal Care Use Committee (IACUC).
SUPPORT PROTOCOL 1   Breeding and Genotyping of RiboTag Mice
Breeding of RiboTag Mice:  
We maintain a live colony of RiboTag Breeders on a C57BL/6J background by mating 
homozygotes since they have no adverse phenotypes. Experimental mice for RiboTag 
assays are usually obtained by breeding male Cre recombinase-expressing mice to 
female homozygous RiboTag mice (Rpl22HA/HA), Therefore, experimental mice are 
always heterozygous for the RiboTag allele (Rpl22HA/+). 
PCR Genotyping:  
To genotype the RiboTag mice, a PCR was developed that includes the loxP site 5’ to 
the wild-type exon 4 of Rpl22; the wild-type PCR product is 242 bp, while the mutant 
product is about 290 bp. This PCR also distinguishes homozygous RiboTag mice, as the 
5’ oligo corresponding to the intron between exons 3 and 4 of Rpl22 is not present in the 
repeated segment of intron preceding the C-terminal Rpl22HA exon 4. Resulting 
offspring from RiboTag mice bred to Cre recombinase-expressing mouse lines 
(experimental mice) are genotyped for the presence of the Cre recombinase gene and 
the RiboTag allele using the PCR oligonucleotides and reaction conditions described 
below
Materials:
NucleoSpin Tissue DNA extraction kit (Macherey-Nagel cat No. 740952)
DreamTaq DNA polymerase (Thermo Fisher Sci. cat No. EP0702 and B71)
dNTPs 10 mM each (Thermo Fisher Sci. cat No. R0192)
 (dilute to 2.5 mM for each dNTP) 
Alternative:
Phire Tissue Direct PCR Master Mix kit (Thermo Fisher Sci. cat No. F170
Oligonucleotides for RiboTag genotyping:
RiboTag loxP For: 5’-GGGAGGCTTGCTGGATATG-3’ 
RiboTag loxP Rev: 5’-TTTCCAGACACAGGCTAAGTACAC-3’
Oligonucleotides For Cre recombinase genotyping:
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Cre cDNA For: 5’-GCATTACCGGTCGATGCAACGAGTG-3’ 
Cre cDNA Rev: 5’-GAACGCTAGAGCCTGTTTTGCACGTTC-3’
Acrylamide-bis solution 40% (37.5:1) (Merck cat No. 1.00638.1000)
Tris-Borate-EDTA (TBE) 10x (Fisher Scientific cat No. BP1333)
Ammonium Persulfate (APS; Sigma cat No. A3678).
(Prepare a 10% solution. Store at 20ºC.)
TEMED (Merck cat No. 1.10732.0100)
SYBR Safe DNA gel stain (Thermo Fisher Sci. S33102)
100 bp DNA ladder (Thermo Fisher Sci. cat No. SM0241)
Equipment:
Thermal cycler (Thermo Fisher Sci. cat No. A24811)
Mini protean vertical gel electrophoresis system (Bio-Rad cat No. 1658003)
Power supply (Bio-Rad cat No. 1645050)
UV Gel imaging system 
Strip tubes and caps for PCR
Protocol steps:
1. Extract DNA from mouse tail snips (2-5 mm) using a silica membrane column-based 
kit such as the NucleoSpin Tissue following manufacturer’s directions. 
We have also successfully used direct PCR kits that do not require prior DNA 
extraction such as the Phire Tissue Direct PCR Master Mix kit for RiboTag and 
Cre recombinase genotyping. DNA can also be extracted from tail samples by 
conventional methods using SDS/Protease K digestion, phenol/chloroform 
extraction, and ethanol precipitation.
2. Prepare the DreamTaq PCR Master mix as follows: (per reaction) 13 µl of water, 2 µl 
of 10x DreamTaq green buffer, 2 µl of 10mM dNTPs, 1 µl of the forward oligo 
(10uM), 1 µl of the reverse oligo (10uM), 0.1 µl of DreamTaq polymerase. Mix gently 
and briefly centrifuge.
3. Add 19 µl of the master mix to each well.
4. Add 1 µl of tail DNA (~2 ng) to each reaction. 
5. Mix and briefly centrifuge.
6. Place strips in the thermal cycler and run the appropriate program for each reaction. 
Thermal profile for RiboTag reactions is: 95°C for 2 min followed by 30 cycles of 
95°C for 20 s, 57°C for 20 s, and 72°C for 30 s, with a final extension at 72°C for 5 
min. Thermal profile for Cre reactions is 95°C for 2 min followed by 30 cycles of 95°C 
for 10 s, 63°C for 10 s, and 72°C for 40 s, with a final extension at 72°C for 5 min.
7. Prepare a 10% acrylamide gel by mixing (for two gels) 14 ml of water, 5 ml of 40% 
acrylamide-bis, 1ml of TBE 10x, 30 µl of TEMED and 150 µl of 10% APS. Allow gels 
to polymerize for 10-15 min.
8. Place gels into a vertical gel electrophoresis system, add buffer (0.5X TBE), and load 
DNA ladder and PCR reactions. 
9. Run the electrophoresis at 175v (constant voltage) for 45 min. 
10. Stain gels with SYBR safe and analyze PCR products under UV light. 
 
Detecting “Ectopic” Cre Recombination in tail DNA
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Mouse lines driving Cre recombinase expression under cell type specific promoters 
should typically restrict RiboTag activation to the cell type of interest. However, transient 
expression of Cre recombinase during development is often observed in different Cre 
driver lines and can lead to recombination of the RiboTag allele in unexpected cell types. 
If this “ectopic” expression takes place in the fertilized egg or during early development, 
it will be detected during the RiboTag genotyping PCR and a “recombination” band will 
show up at ~350 bp. If recombination occurs in the fertilized egg the loxP band will be 
replaced by the “recombination” band. If Cre recombinase is expressed during early 
development, recombination of the RiboTag allele will only take place in a portion of the 
cells and both the loxP and the recombination band will show up during PCR analysis. If 
genotyping heterozygous animals (Rpl22HA/+), the wild-type band will always be present 
in the PCR assay independently of the potential recombination events that may take 
place on the floxed allele. 
SUPPORT PROTOCOL 2  qRT-PCR analysis
The success of the RiboTag procedure can be assessed by using qRT-PCR to evaluate 
whether specific mRNAs have been enriched during the isolation.  Transcripts from the gene 
that is driving the Cre-recombinase in the specific cell types should be enriched in the IP RNA 
sample compared to the input RNA.  We also recommend monitoring mRNAs that are not 
expected to be expressed in the targeted cells to verify that they are de-enriched in the IP.  
Quantitative RT-PCR may substitute for a more expensive and time-consuming analysis by 
RNA-Seq when only a small subset of transcripts need to be assessed.
Materials:
Equipment:
Real-Time PCR machine
Reagents:
We use the one step Brilliant II or III SYBR green kits from Agilent or RNA-Ct one step 
kits from Thermo Fisher Sci.
1. To confirm the specific isolation of transcripts from the cell type of study, we analyze 
RNA extracted from Inputs and IPs by single-step qRT-PCR.  The enriched presence of 
known cell type-specific transcripts in the IPs compared to inputs indicates that the 
RiboTag isolation was successful.
2. Test samples for expression of transcripts specific to cell types in the dissected area 
other than the one of interest such as a glial marker when using a neuron-specific Cre 
transgenic. These are expected to appear depleted in the IPs when compared to inputs. 
3. Perform qRT-PCR analysis for a housekeeping gene such as Actb. Normalizing all data 
to that standard can help correct for errors in RNA quantitation or differences in RNA 
quality. Adding equal amounts of RNA to the qRT-PCR reaction for all samples results in 
little variation in the CTs obtained for the housekeeping gene (less than 1 CT of 
difference is expected among all samples), which confirms RNA integrity in all samples 
and suitability of the housekeeping gene for data normalization.
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BASIC PROTOCOL 2:  RiboTag mice as a reporter mouse line for direct visualization of 
Cre recombination
Materials:
Mice:
RiboTag mouse line (JAX stock No. 011029)
Cre-driver mouse line of choice 
Reagents:
Normal Donkey Serum (Jackson ImmunoResearch cat. No. 017-000-121)
Zymed’s rabbit anti-HA antibody (Thermo Fisher Sci., cat. No. 71-5500
Covance’s Alexa Fluor 488-conjugated mouse anti-HA antibody (BioLegend,cat. No. A488-
101L)
Alexa Fluor 488 donkey anti-rabbit antibody (Thermo Fisher Sci., cat. No. A21206)
SuperFrost plus slides (Thermo Fisher Sci. cat No. J1800AMNT)
Coverslips 24 x 60 mm #1 (Menzel-Glaser, available through VWR cat No. 631-1339)
Fluoromount G with DAPI (Electron Microscopy Sciences, cat. No. 17984-24)
Equipment:
Netwells (Corning CLS3477)
Nutator mixer (e.g. Boekel or Clay Adams)
Paint brush
Protocol steps:
Tissue preparation
1. Transcardially perfuse mice with ice-cold phosphate-buffered saline (PBS) pH 7.4 
containing 4% paraformaldehyde (PFA). 
Perfusion with fixative solution reduces background resulting from endogenous 
mouse IgG detection when using anti-mouse secondary antibodies. If no primary 
antibodies raised in mouse are used for staining, brains can by directly fixed after 
removal by immersion in fixative for 12-24 h. 
2. Remove brains and postfix overnight at 4ºC in PBS pH 7.4 containing 4% PFA. 
3. Wash brains twice in ice-cold PBS pH 7.4
4. Immerse brains in an ice-cold solution of 30% sucrose in PBS pH 7.4. Specimens will 
float. Keep at 4ºC until they sink (about 24 h)
5. Remove brains from the cryoprotective solution and pat dry to remove excess solution
6. Freeze in powdered dry ice for 5 min and store at -80 ºC until sectioning.
7. Cryo-section brains in 30 um-slices using a freezing microtome. Collect sections from 
the area of interest for free-floating staining in PBS pH 7.4 with 0.02% sodium azide as 
preservative. Store sections at 4º.
Imunofluorescence
8. Use a paint brush to transfer sections to wells containing Netwells inserts filled with PBS 
pH 7.4. Rinse sections once with PBS to remove preservative.
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9. Block sections in PBS with 0.2% Triton X-100 and 10% normal donkey serum (NDS) for 
1 h at room temperature with agitation.
10. Incubate overnight at 4ºC with a primary antibody solution containing an anti-HA 
antibody such as the Zymed’s rabbit anti-HA (#71-5500 Thermo Fisher Sci; use at 
1:1000), or with a fluorophore-conjugated anti-HA antibody such as the Covance’s Alexa 
Fluor 488-conjugated mouse anti-HA antibody (# A488-101L BioLegend, use at 1:500), 
in PBS pH 7.4 with 1% NDS and 0.2% Triton X-100. 
Fluorophore-conjugated antibodies allow for a direct visualization of the signal 
without secondary antibody detection. Using fluorophore-conjugated secondary 
antibodies will however provide an amplified signal.
11. Wash sections three times for 5 minutes in PBS pH 7.4 with 0.2% Triton X-100. If a 
fluorophore-conjugated anti-HA antibody is used proceed to step 13. 
12. Incubate with secondary antibody solution containing an anti-rabbit antibody conjugated 
to the fluorophore of choice (e.g., Alexa Fluor 488; Invitrogen; 1:500 in PBS pH 7.4 with 
1% NDS and 0.2% Triton X-100) for 1 h at room temperature.
13. Wash sections three times for 5 minutes in PBS pH 7.4 with 0.2% Triton X-100
14. Mount stained sections onto slides for imaging using Fluoromount G with DAPI.
15. Seal the edge with nail polish and allow slides to dry for 1-2 hours before visualizing. 
Protect from light.
16. Slides can be stored at 4ºC protected from light. For best results, slides should be 
analyzed within 1-2 weeks using the microscope of choice. Staining using anti-HA 
antibodies in Cre-positive RiboTag mice results in a strong perinuclear signal in the cell 
type of interest. 
17. Image slides on a fluorescent microscope (standard or confocal) to visualize the Alexa 
Fluor 488 and DAPI.
DAPI will bind DNA and light up the nuclei in all cells and Alexa fluorescence will 
only be present in the cells that are expressing RiboTag.  Expect to see most of 
the RiboTag labeling in the cytoplasm where polyribosomes are abundant and in 
the nucleolar structures in the nucleus where ribosomes are being assembled.
BASIC PROTOCOL 3: RNA-Seq Library Preparation
There are many library preparation kits on the market but Trio RNASeq (NuGEN) has worked 
well in our hands. A detailed protocol is available on NuGEN’s website (NuGEN). Briefly, 500 pg 
– 50 ng of total RNA in a volume of 10 ul is used as starting material for samples. We 
recommend using similar quantities of RNA for all samples that are going to be compared with 
each by RNA-Seq.  We have good results starting with ~2 ng of total RNA.
Materials
Trio RNA-Seq, mouse rRNA, part number 0507-X; (X = 8, 32, or 96), (NuGEN)
AMPure XP, reference number A63880, (Beckman Coulter)
NEBNext Library Quant Kit for Illumina, catalog number E7630X (X = S, or L), (NEB)
NextSeq 500/550 High Output Kit v2.5 (75 Cycles), catalog number 20024906, (Illumina)
200 mM NaOH
200 mM Tris, pH 7.0
0.2 mL PCR tubes (flat top optically clear)
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1.5 mL microtubes 
0.2 mL tube magnetic rack 
Equipment:
Thermal cycler (PCR machine)
Quantitative thermal cycler
NextSeq Sequencer (Illumina)
Convert isolated RNA from RiboTag into cDNA libraries
1. Perform DNase treatment using the Trio RNASeq kit.  
Although DNA digestion is performed on the RNA purification column, the first 
step of the Trio RNASeq kit is to perform DNase treatment. It is extremely 
important to eliminate any residual DNA and the second DNase treatment does 
not result in any loss of sample. 
2. Synthesize cDNA from the total RNA using reverse transcriptase primed with both oligo 
dT and random hexamers and then use DNA polymerase to produce a double stranded 
cDNA molecule
These primers include an RNA sequence at the 5’ end that is not complementary 
and does not hybridize to the sample RNA. Then a second strand is made with a 
DNA polymerase (Dafforn et al., 2004; Kurn et al., 2005).  
3. Purify double stranded cDNA using silicon coated magnetic beads (AMPure XP, 
Beckman Coulter). 
These beads are used several times throughout the protocol adding various 
amounts of a salt containing bead binding solution. By varying the salt 
concentration in the reaction, one is selecting for different fragment sizes, with 
more salt attracting almost all fragment sizes and less preferentially selecting for 
larger fragments (Boom et al., 1990; Melzak, Sherwood, Turner, & Haynes, 
1996).
4. Amplify the double-stranded cDNA using single primer isothermal amplification (SPIA). 
RNase H is used to digest the RNA portion of the RNA / DNA heteroduplex at 
one end of the double stranded cDNA. A 5’ RNA 3’ DNA primer and a strong 
strand displacing DNA polymerase are used to make a single stranded cDNA 
that is the compliment to the original RNA. The process is continually repeated all 
at one temperature making many such copies (Dafforn et al., 2004; Kurn et al., 
2005). 
5. Fragment and repair ends of the cDNA
The kit accomplishes this using an enzymatic process. After fragmentation 
adapters are ligated to either side of the cDNA with the 3’ side receiving a unique 
nucleotide barcode that will be used to identify samples after sequencing. 
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6. PCR Amplification of cDNA products.  
The kit uses two PCR amplifications with a targeted step in between designed to 
deplete any cDNAs that would have been made from ribosomal RNA. Oligo 
probes are designed to bind to rRNA derived cDNA, extend that product, then 
restriction enzymes target these cleaving the adaptors off these products 
essentially eliminating them from the library. 
  
Quantify cDNA libraries
Even starting at the low end of the kit’s range 500 pg of total RNA, one ends up with 
micrograms of cDNA. This needs to be greatly diluted before sequencing. To get the 
best results from the sequencer the cDNA libraries must be loaded on at a precise 
quantity. As well, each sample that will be multiplexed together should be loaded in 
equal quantities. The most accurate way to quantify the cDNA libraries is using qPCR 
against the adaptors on the cDNA fragments. Again, there are many kits on the market 
that can accomplish this but NEBNext has worked well in our hands.
Four standard samples come with the kit ranging from 0.01 pM to 10 pM. In order to fall 
within these one needs to make serial dilutions of the libraries and use a range of those 
samples to quantify. In our hands 1:100,000 and 1:1,000,000 are the two dilutions that 
will fall between the given standards. Our libraries are most often between 0.1 and 1 µM. 
A detailed user manual is available on NEB’s website (NEB, 2017).
Denature and dilute libraries
The day of the sequencing run, libraries need to be denatured and diluted. A detailed 
protocol is available on Illumina’s website (Illumina, 2018a). 
1. Make a 1 nM dilution of each sample to be multiplexed together using a portion of the 
libraries made earlier. Add an equal amount of each 1 nM sample to a master sample.
2. Add 20 uL of the master sample to 20 uL of 0.2 M NaOH. Mix by pipetting half of the 
volume 10 to 20 times. Incubate for 5 minutes. 
3. Add 20 uL 0.2 M Tris pH 7 to neutralize the NaOH. Mix well by pipetting. 
4. Add 940 uL of prechilled HT buffer provided with the NextSeq reagents to make a 20 pM 
dilution. Vortex briefly then spin the contents down. Keep the 20 pM sample on ice until 
you are ready to make the final dilution.
5. Add 117 uL of the 20 pM sample to 1183 uL of prechilled HT buffer for a final dilution of 
1.8 pM in 1.3 mL. Vortex briefly then spin the contents down. Keep this on ice until you 
are ready to load this on the sequencer. 
Sequencing
1. Thaw reagents cartridge at 4 degrees overnight. Take the reagents cartridge and flow 
cell out of the refrigerator 30 minutes to an hour before your sequencing run. Ensure all 
reagent have thawed before proceeding.
2. From the NextSeq500’s software interface select Sequence.
3. Following the instructions on screen, load the flow cell.
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4. Empty the spent reagents container into the appropriate waste container, then reload. 
Load buffer cartridge. 
5. Pierce the foil covering reservoir 10 on the reagent cartridge with a pipette tip. Then load 
the full volume of the 1.8 pM sample into reservoir 10. Load the reagent cartridge onto 
the NextSeq500. 
6. Specify the run parameters on the setup screen. Assign a name to Run Name, enter 75 
into Read 1 and 8 into Index 1. 
Single end reads may be sufficient for gene expression quantification and 
differential gene expression analysis. Running paired end reads will increase 
alignment confidence for specific isoforms and for novel transcript discovery. In 
this case you would enter 75 into “Read 2”. NextSeq high output cartridges are 
rated for 400 million single end or 200 million paired end reads. 
7. Select Next, the system will run through a number of checks. Once it has finished with 
these select Start. 
A detailed user guide including  instructions for loading reagents and sample 
onto the NextSeq sequencer is available on Illumina’s website (Illumina, 2018b). 
Once reagents and sample have been loaded on the NextSeq and the 
sequencing run has begun, the multiplexed sample is washed over the flow cell 
where cDNA molecules with adaptors hybridize to an oligo lawn with 
complementary sequences. A DNA polymerase makes a compliment to the 
original cDNA molecule primed from the oligo attached to the flow cell, the 
double stranded cDNA is denatured, and the original cDNA molecule is washed 
away. The attached compliment binds a second oligo attached to the flow cell, 
and is copied by a DNA polymerase in a process called bridge amplification. The 
process is repeated many times over until a cluster of cDNA molecules grows 
that will be large enough for the sequencer to read. Fluorescently labeled dNTPs 
are washed over the flow cell where they incorporate into the growing DNA 
strand primed off the template attached to the flow cell. This process is used to 
identify the sequence of both the DNA library fragments made from the original 
samples and the nucleotide barcode ligated to that DNA that identifies which 
sample it comes from (Illumina, 2016). 
 BASIC PROTOCOL 4: RNA-Seq Bioinformatics
The analysis of RNA-Seq data can be done using a variety of open source or proprietary 
programs.  If you are using a Core Facility to do RNA-Seq they are also likely to be able to 
analyze the data for you or at least assist you in the basic steps to obtain the aligned datasets.  
We build the libraries and run the RNA-Seq ourselves and use the methods described below to 
analyze the data.
Software
Software for Linux OS:
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Bcl2fastq2 (Illumina, 2017a)
Software for Linux OS or Mac OS:
FASTX-Toolkit (Hannon_Lab, 2014)
TopHat2 (Trapnell et al., 2016)
Bowtie2 (Langmead, Kim, Charles, Wilks, & Antonescu, 2018)
Cufflinks (Trapnell et al., 2014)
Software for Linux OS, Mac OS, or Windows OS:
R (Gentleman et al., 2018)
RStudio (RStudio, 2018)
tidyr (Wickham & Henry, 2018)
dplyr (Wickham, François, Henry, & Müller, 2018)
ggplot2 (Wickham, Chang, et al., 2018)
Convert BCL files to FASTQ files
Illumina sequencers generate per cycle base call (BCL) files. However, most informatic 
programs take FASTQ or FASTA files as input. Bcl2fastq2 software is able to covert the files, as 
well as, demultiplex samples. A detailed user guide is available on Illumina’s website including 
system requirements for the software (Illumina, 2017b).
1. Create a sample sheet with sample names, numbers, and corresponding nucleotide 
barcodes. This is saved as a .csv in the following format:
[Data],,  
Sample_Name,Sample_ID,Index
Sample1,1,CGCTACAT
Sample2,2,AATCCAGC
Sample3,3,CGTCTAAC
Etc.
2. Run the blc2fastq2 in Terminal (denoted with $ hereafter) with the following options:
$ bcl2fastq --minimum-trimmed-read-length 0 --mask-short-adapter-reads 0 --no-lane-
splitting -o /output_folder -R run_folder --sample-sheet run_folder/SampleSheet.csv
Explanation:
blc2fastq – calls the program.
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minimum-trimmed-read-length – specifies a length to not trim if trimming adapters will 
result in a read of less than this length. In these cases, the adapter portion will be 
masked by replacing base calls with Ns. By specifying 0 we are telling the program to 
trim adapters no matter the remaining length of the read. Default is 35.
mask-short-adapter-reads – specifies a length of a read that if it falls below will be 
masked by Ns. By specifying 0 we are instructing the program not to do this. Default is 
22 (must be set equal or lower than minimum-trimmed-read-length).
no-lane-splitting – this option instructs the program to include all reads for each given 
sample in one file. Without this option the NextSeq will give four files for each sample, 
one for each of lanes 1-4. If the researcher is planning to upload FASTQs to Illumina’s 
basespace.com they should not call this option as basespace will only accept sample 
files that do have lanes split.
-o – specifies the output folder.
-R – specifies the run folder or where the BCL files are located.
--sample-sheet – points to where the sample sheet is located. 
Trim and filter FASTQ files
3. Trim the first 5 base calls and filter out low quality reads. FASTX-Toolkit tools can 
accomplish this with the following command:
$ for i in sample1 sample2 sample3 etc; do zcat $i_S1_R1_001.fastq.gz | fastx_trimmer 
-f 6 -v -Q33 | fastq_quality_filter -q 25 -p 80 -v -Q33 -z -o $i.fastq.gz; done
Explanation:
Commonly known as a “for loop”.
for i in sample1 sample2 sample3 etc – is a list of your samples to iterate over.
do X – could be any command. This command will then iterate over your list.
done – tells the command to stop.
$i – is the placeholder where the list of samples will be substituted in.
zcat – looks at a compressed file.
| – called a pipe, it sends information from first command to the next command.
fastx_trimmer -f 6 – this option says trim the first 5 base calls and keep everything from 6 
onward.
fastq_quality_filter -q 25 -p 80 – this option says only keep reads with a quality score of 
25 or higher on at least 80% of the base calls.
-z – is the option to compress output file.
-o – is the name of file or directory name/name of file.
Align FASTQ files to a reference genome
We use TopHat2 (Kim et al., 2013; Trapnell, Pachter, & Salzberg, 2009) for alignment against 
GRCm38/mm10 UCSC. Useful links to reference genomes with prebuilt bowtie indexes and 
GTF transcript annotation files can be found here: 
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http://ccb.jhu.edu/software/tophat/igenomes.shtml. A detailed protocol for TopHat has been 
published elsewhere (Trapnell et al., 2012). 
4. Use the following command for alignments:
$ for i in sample1 sample2 sample3 etc; do tophat2 -p 8 -G genes.gtf -o output_folder/$i 
Bowtie2Index/genome folder_with_fastqs/$i.fastq.gz; done 
explanation:
tophat2 – is a program that performs alignment.
-p 8 – specifies the number of CPU processors to use. Check your system information 
and set this at or below the total number of logical cores on the computer running the 
software. 
-G – points to directory and .gtf file. 
-o – points to output directory and /$i – is the placeholder for sample. 
Sequence/Bowtie2Index/genome – points to directory with index files. 
folder_with_fastqs/$i.fastq.gz – points to directory and fastq files. This is the actual 
sequencing data.
Quantify and compute differential gene expression
We use cuffdiff of cufflinks (Roberts, Trapnell, Donaghey, Rinn, & Pachter, 2011; Trapnell et al., 
2013; Trapnell et al., 2010) to compute differential gene expression. A detailed protocol has 
been published elsewhere (Trapnell et al., 2012).
5.  Use the following command to calculate differential expression:
$ cuffdiff -p 8 -no-update-check -o output_folder -b Bowtie2Index/genome.fa -u genes.gtf 
-L condition1,condition2 
\./tophat_folder/condition1_S1/accepted_hits.bam,./tophat_folder/condition1_S2/accepte
d_hits.bam,tophat_folder/condition1_S3/accepted_hits.bam,etc 
\./tophat_folder/condition2_S1/accepted_hits.bam,./tophat_folder/condition2_S2/accepte
d_hits.bam,tophat_folder/condition2_S3/accepted_hits.bam,etc
explanation:
cuffdiff – is a program to test for differential gene expression.
-p 8 – this option specifies how many CPU processors to use. 
-no-update-check – use this option as the software is no longer being updated.
-o – points to folder you want your results saved in.
-L – name of your two conditions e.g. control, treatment or input, IP. 
-b – this option corrects for RNA-seq read coverage bias (Roberts et al., 2011). 
-u – this option performs an initial estimate to improve accuracy when weighting reads 
mapping to multiple locations.
We run cuffdiff first on inputs vs IPs within conditions and then IP vs IP across 
conditions. In some cases, one may only be asking what is unique about these 
cells within this tissue. In which case one would only compare input to IP. It is 
important to note that genes that are expressed widely in the total population of 
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neurons will not show up as differentially expressed even if they are expressed in 
the targeted neuron population.  The difference between IP and input will only be 
significant when a transcript is preferentially expressed in the HA-tagged neuron 
population. 
Visualize results
Use R within RStudio to visualize your results utilizing tidyr, dplyr, and ggplot2 packages 
(Wickham, 2016). 
6. If necessary, install packages.
> install.packages(“tidyr”)
> install.packages(“dplyr”)
> install.packages(“ggplot2”)
Load packages.
> load(tidyr)
> load(dplyr)
> load(ggplot2)
7. Import output files “gene_exp.diff” and “genes.read_group_tracking” from cuffdiff and 
save them as an object. The names of the objects are arbitrary; however, good object 
names should be short but descriptive. Below the first named object “cdstats_aipvn” 
describes cuffdiff statistical output for condition A, IP vs input. The example below 
assumes the three cuffdiff output folders are saved in the working directory the R-project 
is started in. 
> cdstats_aipvn <- read.delim(“cuffdiff_A_IP_vs_N/gene_exp.diff”)
> cdstats_bipvn <- read.delim(“cuffdiff_B_IP_vs_N/gene_exp.diff”)
> cdstats_avb <- read.delim(“cuffdiff_A_vs_B/gene_exp.diff”)
> cdfpkms <- read.delim(“cuffdiff_A_vs_B/genes.read_group_tracking”)
8. Below are three examples of creating a list of genes expressed at certain thresholds in 
the IP relative to the input in condition A. 
> A_2fold <- filter(cdstats_aipvn, q_value < 0.05, log2.fold_change. > 1, value_2 > 5) 
%>% select(“test_id”)
> A_1fold <- filter(cdstats_aipvn, log2.fold_change. > 0, value_2 > 5) %>% 
select(“test_id”)
> A_half_fold <- anti_join(dr1stats, filter(dr1stats, log2.fold_change. < -1, q_value < 
0.05), by = "test_id") %>% filter(value_2 > 5) %>% select("test_id")
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9. Filter condition B the same way, then join the 2 lists to create a list of genes that could 
be important in either condition A or condition B.
> AB_2fold <- full_join(A_2fold, B_2fold)
10. Now the new list of genes that could be important in either condition can be used to filter 
for genes that one would want to compare across conditions.
> AIP_vs_BIP <- inner_join(AB_2fold, cdstats_avb, by = “test_id”)
Cuffdiff includes a column in the output file gene_exp.diff labeled “significant” that 
can be useful while graphing data assigning different colors to the binomial 
values (“yes” or “no”). However, we find it useful to append additional columns 
that can specify other criteria, for example, both statistically significant and 
meaningfully different. 
11. In the example below, we are using 2-fold again.
> temp1 <- filter(AIP_vs_BIP, abs(log2.fold_change.) > 1, q_value < 0.05) %>% 
mutate(DE = “yes”)
> temp2 <- anti_join(AIP_vs_BIP, temp1, by = “test_id”) %>% mutate(DE = “no”)
> AIP_vs_BIP2 <- full_join(temp1, temp2)
12. A common graph made with RNA-Seq data is a volcano plot. This plots p-value vs fold 
change, usually both have been log transformed. One can now use the newly created 
“DE” column to highlight genes that are both 2-fold different and statistically different.
> volcplot <- ggplot2(AIP_vs_BIP2, aes(log2.fold_change., -log(q_value), color = DE) + 
geom_point(alpha = 0.5) 
By saving the plot as an object (“volcplot”) it is easy to call up the object and 
modify various aspects experimenting with different options until one is satisfied 
with the plot’s appearance. Below we have modified the default colors of the 
points to black and red, drawn a horizontal line where the corrected p-value is 
0.05, drawn lines indicating where the fold change is 2-fold, and selected a 
different theme (Figure 2A). We like the way theme_classic and theme_bw look 
but this is purely a matter of preference. 
> volcplot + scale_color_manual(values=c("black", "red")) + geom_hline(yintercept = -
log(0.05)) + geom_vline(xintercept = c(-1,1)) + theme_bw()
Another common plot one could make is a scatter plot, plotting log transformed values 
for a list of genes with condition A on one axis and condition B on the other. 
> scatplot <- ggplot(AIP_vs_BIP2, aes(log2(value_1), log2(value_2), color = DE)) + 
geom_point(alpha = 0.3) +
scale_color_manual(values = c("black", "red")) +
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theme_classic()
One can relabel the axis and give the plot a title if they wish (Figure 2B). 
> scatplot + labs(x = "A log2(FPKM)", y = "B log2(FPKM)", title = "A vs B") +
theme(plot.title = element_text(hjust = 0.5)) +
theme(text = element_text(size = 20))
Finally, one may wish to plot individual genes of interest:
Boxplot
> box_geneA <- filter(cdfpkm, tracking_id == "GeneA") %>%
ggplot(aes(condition, FPKM, fill = condition)) + 
geom_boxplot() +
theme_bw() +
theme(legend.position="none") +
scale_fill_manual(values = c("white", "red")) +
ylim(0,NA)
Add a title using labs, center justify using hjust, and change the font size with element 
text (Figure 2C).
> box_geneA + labs(title = “GeneA”) +
theme(plot.title = element_text(hjust = 0.5)) +
theme(text = element_text(size = 20))
Bar chart 
> bar_geneA <- filter(cdfpkm, tracking_id == "GeneA") %>%
ggplot(aes(condition,FPKM)) + 
stat_summary(fun.data="mean_se", geom="bar", color="black", aes(fill=condition)) + 
stat_summary(fun.data="mean_se", geom="errorbar", width=0.3, color="black") + 
theme_bw() +
theme(legend.position="none") +
scale_fill_manual(values = c("white", "red")) +
labs(title = “GeneA”) +
theme(plot.title = element_text(hjust = 0.5)) + 
theme(text = element_text(size = 20))
Add in individual data points for greater data reporting transparency (Figure 2D).
> bar_geneA + geom_point(size = 3) 
[*Copy Editor – Insert Figure 2 here]
REAGENTS AND SOLUTIONS
Tris base (Sigma; cat. No. T1503). 
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 Prepare a 1.5M pH 7.4 stock solution (pH with HCL) and store at 4ºC
KCl (Sigma; cat. No. P9541). 
 Prepare a 1M stock solution and store at 4ºC
MgCl2 (Sigma; cat. No. 63068). 
 Prepare a 1M stock solution and store at 4ºC
Nonidet P-40 Substitute, 10% (w/v) solution (Roche, cat. No. 11 332 473 001)
Cycloheximide (Sigma, cat. No. C7698).
 Prepare a 5mg/ml stock solution and store at -20ºC.
Heparin (Sigma; cat. No. H3393). 
 Prepare a 100 mg/ml stock solution and store at 4ºC.
Phosphate buffered saline (PBS), tablets (Millipore, cat. No. 524650-1EA). 
 Prepare at 1x with water.
Paraformaldehyde (Sigma cat. No. P6148). 
 Prepare a 4% solution in PBS 1x. Adjust pH to 7.4. Prepare fresh and store at 4ºC.
Sucrose (Sigma cat. No. 84097). 
 Prepare a 30% solution in PBS 1x pH 7.4. Store at 4ºC.
Sodium Azide (Sigma, cat. No. S2002). 
 Prepare a 0.02% solution in PBS pH 7.4
Triton X-100 (Millipore, cat. No. 648466). 
 Prepare a 0.2% solution in PBS pH 7.4.
 
Homogenization buffer: 
 50 mM Tris pH7.5
 100 mM KCl 
 12 mM MgCl2
 1% Nonidet P-40 
 1 mM DTT 
 200 U/mL Promega RNasin 
 1 mg/mL heparin 
 100 ug/mL cycloheximide 
 protease inhibitor mixture (1x)
Optional: The addition of 1% sodium deoxycholate (DOC) to the homogenization buffer 
reduces some of the non-specific background.  We have shown that DOC does not 
significantly reduce the purification of specific polysomes and suggest testing it in your 
experiments. 
Homogenization buffer is prepared by adding defined volumes of stock solutions for Tris 
(1.5M pH 7.4), KCl (1M) and MgCl2 (1M) to nuclease free water to achieve the final 
concentrations described above in the desired volume. Right before homogenization, 
buffer is supplemented with DTT, protease inhibitors, RNasin, heparin and 
cycloheximide.
 
High salt buffer: 
 50 mM Tris pH 7.5 
 300 mM KCl 
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 12 mM MgCl2 
 1% Nonidet P-40 
 0.5 mM DTT
 100 ug/mL cycloheximide 
Prepare using Tris, KCl and MgCl2 stock solutions. Add DTT and Cycloheximide right 
before using. 
COMMENTARY
Background Information
It has been a little over 10 years since the first development of cell-type specific 
ribosome tagging strategies that permitted the analysis of a cell's translatome (the mRNAs 
engaged on polyribosomes) (Heiman et al., 2008).  The original technique utilized BAC 
transgenic mice that were engineered to express a GFP-tagged 60S ribosomal subunit protein 
(Rpl10a) behind a cell type specific promoter.  Antibodies directed against GFP were used to 
immunoprecipitate the tagged polyribosomes from which mRNA could then be isolated and 
analyzed by qRT-PCR, microarray, or RNA-Seq. This approach required the generation of novel 
BAC transgenic mice specific for each cell type and did not take advantage of the many tissue 
specific Cre recombinase mouse lines that were already developed.  
We developed an alternative approach described in this RiboTag protocol in which an 
HA-tagged ribosomal protein (Rpl22) is conditionally expressed from the mouse genome by the 
action of Cre recombinase (Sanz et al., 2009).  This approach takes advantage of the constantly 
expanding diversity of cell type specific Cre recombinase expressing mouse lines.  Both 
approaches suffer from the same limitation: the investigator must have already identified a gene 
promoter that is specific for the cell type of interest.  Although it is unlikely that subtypes of 
neurons can be uniquely defined by the expression of a single Cre recombinase transgene, the 
ribosome tagging strategies have facilitated analysis of the mRNAs engaged with 
polyribosomes in many neuronal cell types and can also be used to study the regulation of 
specific genes in vivo.
One alternative approach that has rapidly been adopted by neuroscientists is single cell 
transcript analysis by direct RNA-Seq.  A single anatomical structure such as the arcuate 
nucleus of the hypothalamus is dissociated into single cells, the transcripts from each cell are 
uniquely barcoded, and the RNA is analyzed by RNA-Seq.  Clustering analysis is used to 
identify unique cell types including neurons and glial cells, and then the neurons can be further 
clustered into discreet sub-types based on their transcript phenotype.  This unbiased approach 
is very useful to explore the full range of neurons in a specific anatomical location and will 
rapidly leading to transcriptome phenotypes for all of the neurons and glial cells in a mouse 
brain.  One limitation of this approach is that relatively non-abundant transcripts escape 
detection due to the large number of different cell types being sequenced en masse. Another 
limitation is that the techniques that must be used to obtain single cells, especially starting with 
the brain, can cause alterations in gene expression (e.g. induction of immediate early genes) 
(Moffitt et al., 2018; van den Brink et al., 2017) and may also lose transcripts that are 
sequestered in neuronal processes where they are also likely to be under translational control.  
The ribosome capture approaches like RiboTag will only isolate mRNAs that have ribosomes 
bound to them and are expected to be actively translated into protein. 
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Critical Parameters and Troubleshooting
1.  Cell type Specificity:  The specificity of the RiboTag analysis depends on the 
specificity of the Cre recombinase transgenic mouse line and every effort should be made to 
verify that the Cre transgenic drives expression of Rpl22-HA in the appropriate cell type and 
does not give rise to ectopic expression in other tissues that would interfere with the analysis.  It 
is important to check that recombination of the RiboTag allele is not occurring during early 
development giving rise to mice with variable expression in many other cell types.  This can be 
done by analyzing expression of Rpl22-HA by immunohistochemistry and comparing it to a 
marker for the cells of interest as described in Basic Protocol 2.  We also routinely screen for 
RiboTag recombination in tail DNA during genotyping as described in the Support Protocol 1. 
This will help identify mice that have undergone recombination of the RiboTag allele during early 
development and they should be removed from the cohort to be studied as adults. 
2. Background and Controls:  When we analyze the RNA from a RiboTag experiment 
we find that the immunoprecipitated polysomes still contain mRNAs from cells that are not 
expressing Cre recombinase and Rpl22-HA (e.g. glial cells).  These transcripts are depleted in 
the IP (IP/input ratios <0.3) but since some are abundantly expressed, they will still appear at 
significant levels in the IP.  As described in Basic Protocol 4 we advise analyzing both the input 
and IP RNA and then considering whether to filter out background gene transcripts that are 
depleted.  In some of our experiments we are interested in gene transcripts which are enriched in 
the cell type being studied and help define a unique phenotype for those neurons.  In addition to 
the background of depleted mRNAs seen in the IP we have observed that the IP may also contain 
enriched transcripts from genes that are clearly not expressed in the cell type of interest. These 
false positives can confound the data and we suggest doing a control IP experiment starting with 
equivalent tissue from a mouse that does not express RiboTag.  Transcripts that enrich in the 
absence of Rpl22-HA expression are artifacts of the technique and should be eliminated from the 
specific transcripts isolated when Rpl22-HA is expressed. As described in the protocol we have 
recently been able to reduce the capture of these artifactually enriched genes by including an 
ionic detergent, sodium deoxycholate, in the initial homogenization buffer. 
3.  Anticipated Results and Statistical Analysis:  Each tissue homogenate yields two 
RNA-Seq libraries, an input and an IP.  We typically run 8-16 RNA-Seq libraries on a NextSeq 
500/550 flow cell and expect to have 25-50 million aligned reads for each library.  Statistical 
analysis of this data requires at least 3 replicates making these experiments quite expensive in 
terms of reagents.  If one is trying to phenotype the cells the first analysis would be to determine 
all of the expressed genes comparing IP to input and then to rank those transcripts by the ratio 
of IP to input.  Transcripts that come up as enriched in a control IP from a mouse that does not 
express RiboTag should be removed from this transcript phenotype.  If the animals have been 
treated with pharmacologic agents or exposed to physiological challenges, transcripts that 
change between samples can be identified and statistically analyzed as described in Basic 
Protocol 4.  It is very helpful to correlate the specific transcripts that are enriched in the Cre-
expressing cells with the in situ hybridization results from the Allen Mouse Brain Atlas.  
Specificity can also be confirmed using RNAscope (Advanced Cell Diagnostics) to colocalize 
transcripts in the anatomical region of interest.  One can also confirm results by qRT-PCR 
starting with either the original RNA samples or qPCR with the DNA libraries.  
The RiboTag approach is ideally suited to studying the dynamic regulation of genes in a 
specific neuronal population.  Transcripts can be induced within minutes after the addition of 
hormones and drugs or changes in nutritional or environmental conditions.  When an mRNA is 
specifically induced in the RiboTag targeted cell but constitutively expressed in neighboring 
cells, the level of transcripts in the IP will increase and the enrichment (IP/input) will also 
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increase. If a gene like Fos is induced in all of the cells in the tissue being analyzed, then you 
will see an increase in IP transcripts for Fos but no change in enrichment.
Translational control:  RiboTag techniques will only isolate mRNAs that have 
ribosomes bound and this implies that these mRNAs are being actively translated.  However, it 
is important to consider that RiboTag is not going to be very sensitive to how many ribosomes 
are engaged on a particular mRNA.  For example, if an mRNA is under translational control and 
only has 2-3 ribosomes in the repressed state and 12 or more ribosomes when induced, the 
efficiency of immunoprecipitation may not change enough to be a quantitative indicator of 
translational activity.  Ribosomes may also remain attached to mRNAs even when elongation 
and active synthesis of protein is repressed.
4.  Time Considerations:  One of the advantages of the RiboTag procedure is that 
once the animals are obtained either by mating RiboTag mice with a specific Cre driver 
transgenic or stereotaxically injecting AAV-RiboTag virus and waiting for RiboTag expression, 
the immunoprecipitation of specific RNA can be completed in a day.  Production of DNA 
libraries for RNA-Seq and DNA sequencing can be completed in a few more days.  The most 
time-consuming step is the analysis of results and this depends on what questions are being 
asked and the number of different tissues and conditions being studied.  
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FIGURE LEGENDS
Figure 1.  Cartoon comparing the RiboTag mouse and AAV-DIO-RiboTag approaches
On the left side, the Rpl22 locus was modified by homologous recombination to insert LoxP 
sites on either end of the last exon (Ex4) of the Rpl22 gene and a duplicated Ex4 with an HA tag 
was inserted downstream.  The CRE-Driver mouse removes the WT Ex4 sequence in specific 
cells and the transcript now splices in Ex4-HA (shown in green).  Polyribosomes from cells 
expressing the Ex4-HA are recovered from a lysate by immunoprecipitation (IP) with an 
antibody directed against HA and magnetic beads coated with an artificial Protein A/G peptide.  
RNA is isolated from the IP polyribosomes and RNA is also isolated from the lysate.  Gene 
expression analysis is done by RNA-Seq. On the right side the DIO-RiboTag viral vector is 
shown schematically.  In the presence of Cre-recombinase the Rpl22-HA-IRES-YFP cassette is 
flipped and locked in the ON configuration so that the eIF1a promoter now drives expression of 
Rpl22-HA in specific cells.  RNA is isolated from the IP and compared with the input.
Figure 2.  Example plots of hypothetical RNA Seq data. A, Volcano plot of data with log 
base 2 transformed fold change (condition A vs condition B) plotted on the x axis and negative 
natural log transformed corrected p-value (q-value) plotted on the y axis. The solid horizontal 
line denotes where q-value is equal to 0.05. The two solid vertical lines denote where fold 
change is equal to 2 (or -2). Data points are colored red if they are both 2-fold different and have 
a q-value less than 0.05; otherwise they are black. B, Scatter plot of data with log2 transformed 
fragments per kilobase million (FPKM) plotted on the x axis for condition A and the y axis for 
condition B.  As in A data points are colored red if they are both 2-fold different and have a q-
value less than 0.05; otherwise they are black. C, Box plots for Gene A for condition A and B. 
FPKM are plotted on the y axis with the two conditions represented side by side on the x axis. 
D, Bar graphs denoting mean plus or minus standard error of the mean (SEM) for Gene A for 
condition A and B. FPKM are plotted on the y axis with the two conditions represented side by 
side on the x axis. Individual data points are superimposed on top of the bars for greater data 
reporting transparency. DE, differentially expressed. 
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